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ABSTRACT
EPIGENETIC REGULATION OF PROGENITOR CELL COMMITMENT BY HDAC3
Mudit Gupta
Jonathan A. Epstein

Tissue-specific progenitor cells emerge during development to expand and
differentiate into the multiple cell lineages that populate the embryo. Appropriate
differentiation of these precursor cells requires coordinated expression of numerous
lineage-specific genes and repression of alternative fate programs. Epigenetic regulators
are enzymes capable of activating or silencing large genomic domains by altering
histone modifications, DNA methylation status and chromatin organization. Although
differentiating progenitor cells undergo epigenetic changes and epigenetic factors are
required for appropriate cell behavior, the precise mechanism of how these proteins
influence cell fate remains unclear. In this dissertation, I examine the role of histone
deacetylase 3 in control of neural crest and cardiac progenitor cell commitment. Using
Cre-mediated genetic deletion, I generated tissue-specific mouse models to study the
function of Hdac3 in both neural crest and cardiac cells. These studies revealed a critical
role for Hdac3 in maintaining neural crest proliferation and cell survival through
regulation of a core network of factors required for craniofacial development. In cardiac
progenitors, Hdac3 maintains appropriate differentiation into the cardiomyocyte, smooth
muscle and endothelial cell lineages that make up the developed heart. Hdac3
represses a cardiomyocyte-specific gene program and prevents precocious
differentiation of progenitors into the myocyte lineage. Surprisingly, this protein does not
iii

require deacetylase activity to repress myocyte commitment, and instead serves as a
tether to retain myocyte-specific genomic loci at the nuclear periphery. This novel
mechanism of gene repression and lineage specification highlights the role that nuclear
architecture plays in controlling transcriptional activity and progenitor cell behavior.
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Chapter 1. Introduction

Summary

The cells that make up a developing organism are called upon to proliferate,
apoptose, differentiate or remain uncommitted in a precise and coordinated fashion. To
undergo such dramatic changes, cells must be able to activate and silence broad sets of
genes in a synchronized manner. Epigenetics has emerged as a powerful system of
regulation that enables control of gene expression without changing the DNA itself. In
this chapter, I will summarize how these precursor cells were first defined and studied,
review known regulators of cell behavior and introduce nuclear architecture as a novel
mechanism of epigenetic regulation during development. A portion of this introduction
has been adapted from a chapter written by Jonathan Epstein, Rajan Jain and me for a
textbook on congenital heart disease, “Cardiac Malformation” by Rickert-Sperling, Kelly
and Driscoll which is, as yet, unpublished. The portions included here were primarily
written by me.
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Progenitor cell biology

Patterning of a multicellular organism from a single, totipotent cell requires a
series of commitment steps as the original cell expands and differentiates into the
numerous tissues that make up the body. In mammalian development, development
begins with fertilization of the egg, formation of the zygote and a series of cleavage
events generating the blastocyst. Each blastocyst is a multi-layered structure made up of
an inner cell mass surrounded by the trophoblast layer. The trophoblast eventually forms
extraembryonic structures including the placenta. The inner cell mass, however, is made
up of cells that will give rise to the entirety of the embryo (Hogan et al., 1986). The cells
of the inner cell mass can be isolated and grown in culture, yielding embryonic stem
cells (ESCs). A stem cell is defined as a clonal precursor with ability to both self-renew
and differentiate into more committed progeny. For example, pluripotent ESCs are able
to self-renew, forming more embryonic stem cells, and differentiate into every cell type
found in the embryo.

In contrast to stem cells, the term progenitor has entered common use to refer to
a more differentiated precursor cell. A progenitor cell is defined as a clonal precursor
with a limited set of progeny and no capacity for self-renewal. As development
progresses from the blastocyst stage to specification of the three germ layers
endoderm, ectoderm and mesoderm

to organogenesis, multipotent somatic stem cells

are retrieved to expand and differentiate into tissue-specific progenitor cells that give rise
to more limited sets of progeny that comprise various tissues. These fate decisions
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require precise regulation at each step to ensure cell expansion and differentiation
occurs normally. Proper understanding of the regulatory mechanisms behind progenitor
cell behavior is essential for both identifying the causes of congenital defects and
harnessing stem and progenitor cells for treatment of disease. A hallmark of progenitor
cell differentiation is altered expression of a wide program of lineage-specific genes. For
example, differentiation of a hematopoietic stem cell into a common myeloid progenitor
requires upregulation of dozens of myeloid-specific genes and silencing of a lymphoidspecific gene program, repressing the alternative fate (Weissman et al., 2001). This
simultaneous gene activation and gene silencing requires precise coordination. In this
thesis, I focus on an epigenetic modifier, Hdac3, which functions as a regulator of
progenitor cell fate by synchronizing expression of broad gene programs in both neural
crest and cardiac progenitors.

Hematopoietic progenitors

The best-studied precursor cell is the hematopoietic stem cell (HSC). Through
classical studies in mice, Till and McCulloch injected single precursor cells derived from
bone marrow into lethally irradiated mice and observed colony formation in the spleen
proportional to the number of injected cells (Till and McCulloch, 1961). This seemingly
simple observation was the first direct evidence for the existence of a stem cell with the
capacity to self-renew, repopulate a depleted animal and differentiate into clones of
progeny. From this early observation, our understanding of hematopoietic development
grew as new techniques for identification of specific cell populations with antibodies to
3

surface markers, isolation of marked cells with high-speed cell sorting and assays to
promote derivation of every hematopoietic lineage (reviewed by Weissman et al., 2001).
Utilizing these technologies to characterize the hematopoietic stem cell, the Weissman
group identified a population of multipotent progenitors (MPPs) downstream of HSCs
without the capacity for self-renewal and with a more limited variety of progeny (Morrison
et al., 1997). From the appearance of this first progenitor downstream of HSCs, the
hematopoietic hierarchy branches into myeloid and lymphoid lineages with the common
myeloid progenitor and common lymphocyte progenitor cells. These two cell types give
rise to even more restricted sets of progeny, express different gene programs and can
be isolated individually based on different surface markers. From this point in the
hierarchy, subsequent progenitor cells become even more restricted to differentiating
into a limited number of cell types and still without the capacity to self-renew (Weissman
et al., 2001). Taken together, several decades of classical lineage tracing and clonal
analysis studies have defined a hematopoietic hierarchy that serves as the template for
progenitor cell maturation pathways in a variety of embryonic tissues (Figure 1.1).

Neural crest

Another cell type that exemplifies progenitor cell behavior is the neural crest. The
neural crest is often described as the “fourth germ layer,” giving rise to a wide variety of
lineages and forming a significant portion of the vertebrate embryo. First identified by
Wilhelm His in 1868, the neural crest was originally termed Zwischenstrang, the
intermediate cord, for its physical proximity to the developing neural tube and epidermal
4

ectoderm (reviewed by Achilleos and Trainor, 2012; Crane and Trainor, 2006). Arthur
Milnes Marshall later named this structure the “neural crest,” as it forms upon the fusion
of the two neural ridges dorsal to the “neural canal.”

This remarkable collection of multipotent cells has the ability to differentiate into a
broad range of lineages including neurons of the peripheral nervous system, secretory
cells of the adrenal medulla, smooth muscle, bone and melanocytes (reviewed by Dupin
and Sommer, 2012). Once neural crest cells were identified and isolated in the late
nineteenth and early twentieth centuries, classical fate mapping studies were required to
determine the capacity of these cells. In an early form of lineage tracing, Le Douarin and
colleagues capitalized on the morphological differences between chick and quail cells to
analyze both neural crest differentiation and sensitivity to environmental cues (Le
Douarin et al., 1975). Utilizing a chick-quail chimera system, the authors began by
ablating a portion of the trunk neural tube in chick embryos early in development, before
the onset of neural crest migration. Next, a different segment of neural tube from a
stage-matched quail embryo was grafted onto the chick host and cells were allowed to
migrate from the quail donor into the host tissue. Histological analysis revealed that
neural crest cells from the heterotopic quail graft were able to migrate into the chick
embryo, appropriately differentiate into cholinergic neurons and engraft.

This breakthrough study revealed that quail neural crest cells from a domain that
normally becomes adrenergic neurons have the capacity to differentiate into cholinergic
neurons if placed in the appropriate environment. In vitro studies of cultured chick neural
5

crest cells revealed that this population gives rise to both melanocytes and adrenergic
cells (Bronner-Fraser et al., 1980). Further studies of isolated, single neural crest cells
confirmed that a single progenitor cell has the potential to give rise to both neuronal and
melanocyte cells (Bronner-Fraser et al., 1980). With the advent of vital cell dyes, in vivo
lineage tracing studies of single cells became possible. Labeling of single premigratory
or migrating neural crest cells revealed that at both stages, individual neural crest cells
have the potential to become both neuronal and non-neural cell types (Bronner-Fraser
and Fraser, 1989, 1988). The majority of cranial neural crest cells, for example, give rise
to neuronal, glia and melanocyte lineages. This varied, yet limited differentiation capacity
is consistent with neural crest cells behaving primarily as progenitors, more restricted
than pluripotent stem cell populations.

As noted in the earliest observations of neural crest cells by His and Marshall,
the neural crest forms at the interface between surface ectoderm and the dorsal neural
plate. Once the two halves of the neural plate curl and fuse at the midline to form the
neural tube, this neural plate border comes in direct contact with the surface ectoderm,
initiating a series of cell-cell signaling events that promote induction of the neural crest.
One of the critical signaling cues of this process is establishment of a BMP gradient
(Achilleos and Trainor, 2012). BMP inhibitors secreted by the underlying mesoderm help
form zones of low, medium and high BMP signaling that promote induction of the neural
plate, neural crest and surface ectoderm, respectively (Marchant et al., 1998).

6

After induction and specification at the dorsal neural tube, neural crest cells
undergo an epithelial-to-mesenchymal transition (EMT) to delaminate and begin
migration throughout the embryo. The EMT process involves reorganization of the cell
cytoskeleton, dissolution of cell junctions, remodeling of extracellular matrix components
and activation of several signaling pathways and transcription factors (Achilleos and
Trainor, 2012; Crane and Trainor, 2006). For example, Snail genes are expressed
during EMT and serve as markers of neural crest cells undergoing delamination. This
gene family functions as transcriptional repressors and Snail expression during EMT
downregulates Cadherin genes, depleting cell junctions and allowing delamination and
migration to occur (Taneyhill et al., 2007). Once the cranial, cardiac, vagal and trunk
neural crest cells begin to migrate, they follow well-mapped routes to various
destinations at each axial level to differentiate into the appropriate tissue types. To
navigate these migration routes, neural crest cells express a series of factors to remodel
the extracellular matrix, maintain appropriate cell cycling and respond to guidance cues
(Achilleos and Trainor, 2012; Sauka-Spengler and Bronner-Fraser, 2008). Matrix
metalloproteases including MMP2 permit matrix breakdown, cyclin D1 and D2 are
upregulated during delamination to promote proliferation of migrating neural crest and
expression of Ephrin receptors ensures appropriate guidance of cardiac crest to the
aortic arch arteries.

At each stage of neural crest induction, migration and differentiation, a series of
transcriptional programs are activated or repressed to ensure proper cell function.
Molecular studies in several vertebrate models have identified components of these
gene regulatory networks. Despite outlining the transcription factors and target genes
7

within these networks, our understanding of the upstream activators of the transcriptional
programs and the mechanisms for maintaining their coordinated expression remains
incomplete. Given the number of developmental defects related to neural crest-derived
structures including craniofacial abnormalities and congenital heart diseases, elucidating
the mechanisms controlling neural crest behavior is of critical importance.

Cardiac progenitors

A subtype of neural crest cells, the cardiac neural crest, arises from the otic
placode through the third somite to give rise to elements of the cardiac outflow tract.
Classical work by Kirby revealed that avian cardiac neural crest cells migrate to the
developing aortic arch arteries to differentiate into smooth muscle and also contribute to
the aorticopulmonary septum (Creazzo et al., 1998; Kirby et al., 1983). Aside from the
outflow tract, the majority of the working myocardium arises from several pools of
cardiac progenitor cells (CPC). The heart is the first organ to form in the embryo, with a
detectable heartbeat present in mice by embryonic day 9. Early characterization of
cardiac progenitor cells was performed in chick embryos employing several techniques
also used to investigate the neural crest. In the late 1930s, Mary Rawles cultured
explants from several regions of early chick embryos to map embryonic regions with the
potential to form beating tissue ex vivo (reviewed by Eisenberg et al., 2004). Later,
transplant experiments by Stalsberg and DeHaan utilized radiolabeled tissue fragments
from chick donors to trace migration and engraftment of labeled cells in recipient
embryos (Stalsberg and DeHaan, 1969). More recently, linage tracing with vital cell dyes
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has enabled tracking of individual CPCs and monitoring of differentiation into the various
tissue types found in the heart (Redkar et al., 2001).

These studies used very different methodologies to generate nearly identical fate
maps of cardiac progenitor cells. To summarize the findings of these groups and others,
committed cardiac precursor cells arise from the primitive streak mesoderm. These
mesodermal cells initially express pan-mesoderm marker Brachyury which is replaced
by cardiac-specific Mesp1 expression as the mesoderm begins to commit to the cardiac
lineage (reviewed by Wu et al., 2008). These Mesp1+ precursor cells migrate away from
the primitive streak, expanding and condensing into the anterior and lateral plate
mesoderm on either side of the midline. Once these pockets of CPCs expand medially
and fuse, they are known as the cardiac crescent and begin to express cardiac-specific
transcription factor Nkx2.5. This population of cardiac progenitor cells is known as the
first heart field (FHF), expresses markers Tbx5, Mlc2a and Hcn4 and goes on to
populate the left ventricle and both atria (Liang et al., 2013; Später et al., 2013).
Following specification of the FHF, a second wave of progenitors known as the second
heart field (SHF) emerges posterior to the cardiac crescent, expresses markers Isl1 and
Mef2c-AHF and contributes to the right ventricle, atria and outflow tract (Cai et al., 2003;
Verzi et al., 2005).

The cardiac progenitors of both the FHF and SHF are thought to be multipotent,
with the ability to differentiate into cardiomyocytes, smooth muscle and endothelial cells.
In vitro studies with both embryonic stem cell-derived and explanted tissue have
9

demonstrated that these CPCs contribute to the three cardiac lineages at both the
population and single cell level (Kattman et al., 2006, 2011; Moretti et al., 2006, 2010;
Wu et al., 2006). ESC-derived cardiac progenitor cells express surface markers Flk1 and
PDGFRα, growth factor receptors, enabling their isolation and clonal analysis. Single cell
culture of Flk1+PDGFRα+ cells revealed that each individual progenitor cell has the
capacity to form cardiomyocytes, smooth muscle and endothelial cells (Kattman et al.,
2006). Similar findings were seen with isolated Isl1+ and Nkx2.5+ cells (Moretti et al.,
2006; Wu et al., 2006).

In vivo studies of CPC potential and behavior began with early clonal analysis of
individual fate mapped precursor cells. Pioneering work by Buckingham established the
presence of multiple heart fields and subpopulations within the cardiac progenitor pool
with differing developmental commitments (Meilhac et al., 2004a, 2004b). Subsequent
studies utilizing progenitor-specific Cre alleles confirmed that at the population level,
FHF and SHF cardiac progenitors have the capacity to differentiate into cardiomyocyte,
smooth muscle and endothelial lineages in vivo (Liang et al., 2013; Moretti et al., 2006;
Später et al., 2013; Wu et al., 2006). More recently, inducible, progenitor-specific alleles
have permitted clonal analysis of individual CPCs. These studies suggest that in vivo,
single cardiac progenitor cells have a similar ability to differentiate into multiple lineages
as previously demonstrated in culture (Lescroart et al., 2014; Peng et al., 2013).

Despite significant evidence that cardiac progenitor cells are multipotent and play
a critical role in populating the embryonic heart, the regulatory mechanisms governing
10

CPC differentiation and lineage commitment remain unclear. In vitro culture of ESderived CPCs has enabled identification of individual signaling molecules and
transcription factors required for appropriate progenitor differentiation (Kattman et al.,
2006, 2011), however the broader control mechanisms of CPC behavior remain to be
determined. Culture studies have demonstrated that both BMP signaling and Wnt
inhibition are essential for appropriate commitment to the cardiomyocyte lineage. A
broad array of cytoskeletal and sarcomeric factors must be expressed while alternative
fate genes must be silenced for myocyte specification to proceed. Coordinated
expression of these lineage-specific gene programs is essential to CPC commitment,
and epigenetic regulatory factors have emerged as potential mediators of this genetic
synchronization.

Epigenetics

Introduction

Epigenetics is the study of heritable changes to the genome and gene
expression patterns that are not caused by direct changes to the DNA sequence.
Examples of these changes include post-translational modifications to DNA-bound
histone proteins, DNA methylation and remodeling of chromatin architecture.
Collectively, epigenetic changes are an additional layer of regulation that affects
transcriptional activity of genes while leaving the DNA sequences unaltered (reviewed by
11

Chang and Bruneau, 2012; Lee and Young, 2013; Li and Reinberg, 2011). Sequence
variants or mutations affecting enzymes responsible for modifying or sensing epigenetic
marks have been identified in patients with congenital heart disease (CHD) and small
molecule inhibitors of epigenetic complexes have shown promise as therapies for adult
heart diseases (Anand et al., 2013; Zaidi et al., 2013). Additionally, transgenic mice
harboring mutations or deletions of genes encoding epigenetic enzymes recapitulate
aspects of human disease (Haberland et al., 2009a; Hurd et al., 2010; Trivedi et al.,
2007). Taken together, these findings suggest that the evolving field of epigenetics will
inform our understanding of human disease and offer new therapeutic opportunities.

Coordinated expression of genes coded by the DNA sequence of the genome
requires precise temporal and spatial interactions between protein factors in the nucleus
and the DNA. Work over the last half century has revealed that these interactions are
highly influenced by the manner in which DNA is packaged and organized as chromatin
(reviewed by Zhou et al., 2011). The basic unit of chromatin is the nucleosome, a
complex of 147 bases of DNA wound around an octameric core of histone proteins. The
spacing and number of nucleosomes determines chromatin density, with the DNA within
highly dense heterochromatin being less accessible to nuclear factors than sequences
within relaxed, less dense euchromatin. As a result, genes within heterochromatic
regions tend to be silenced while euchromatic loci are typically active. Clusters of
nucleosomes are further condensed so that the genome can be efficiently packaged into
the nucleus.

12

The first epigenetic modification to be identified was methylation of the DNA
itself. Methylation of cytosine residues is typically associated with transcriptional
silencing, and a number of enzymes are responsible for adding and removing these
methyl groups (Smith and Meissner, 2013). Another type of epigenetic modification
involves post-translational modifications of histone proteins, including methylation and
acetylation of lysine residues. These modifications modulate the recruitment of additional
protein complexes that regulate chromatin density and conformation. A host of “writer”
and “eraser” enzymes exists to add and remove specific modifications from histone tails,
and the description of these growing families of enzymes is rapidly evolving. Histone
methyltransferases and deacetylases are among the most studied of these “writer” and
“eraser” enzymes, respectively, in the context of cardiac development and disease.
Covalent modifications of histone proteins are sensed by “reader” proteins that affect
downstream changes in chromatin in response to changes in epigenetic marks. Included
in this class of proteins are chromodomain-containing proteins such as CHD7, a member
of a larger family of ATP-dependent chromatin remodeling complexes. Mutations in the
gene encoding CHD7 have recently been identified in patients with congenital heart
disease (Hurd et al., 2010).

Epigenetic changes during cardiac development

The explosion of next generation sequencing technologies coupled with the
improved efficiency of directed differentiation of embryonic stem cells into cardiac
lineages has enabled mapping of the landscape of histone modifications over the course
13

of cardiac differentiation. Most prominently, work by the Bruneau and Boyer laboratories
and the Murry group has shed significant light on the dynamics of gene activation and
repression during cardiac specification (Paige et al., 2012; Wamstad et al., 2012). By
taking snapshots at a series of well-defined time points in mouse and human ESC
differentiation, these groups defined the presence of various histone modifications
across the genome during cardiogenesis using chromatin-immunoprecipitation coupled
with massively paralleled sequencing (ChIP-Seq). Specifically they observed unique
histone modifications marking transcription start sites (H3K4me3), enhancers (H3K4me1
and H3K27ac) and inactive chromatin (H3K27me3), thus providing an initial “map” of the
dynamic epigenetic landscape during cardiac development. A theme that emerges from
these surveys is that genes specific to non-cardiac lineages such as endoderm and
ectoderm derivatives are rapidly marked by repressive histone modifications, resulting in
active repression of these lineages. These findings support the hypothesis that cell
differentiation requires active silencing of alternative lineages. These studies also
suggest that cardiac-specific enhancers are marked by monomethylation of lysine 4
(H3K4me1), and further insights will result from integration of the publically available
databases resulting from this work with ongoing studies.

Histone modifications

Epigenetic studies have focused on understanding how histone proteins undergo
post-translational modifications, which amino acid residues are subject to these
modifications and how various combinations of modifications affect gene expression
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(Chang and Bruneau, 2012; Ohtani and Dimmeler, 2011). Methylation and acetylation
are two of the most common and well-studied histone modifications. Histones can be
methylated on a variety of residues and Jumonji domain-containing proteins act as
demethylases. Histone acetyltransferases (HATs) acetylate lysine residues primarily on
histone tails and histone deacetylase enzymes (Hdacs) reverse this process. Additional
forms of histone modification have been described and continue to be discovered,
though application to development and disease awaits further study.

Histone deacetylase enzymes

Histone deacetylases (Hdacs) remove acetyl groups from lysine residues,
typically resulting in compaction of chromatin and repression of gene expression. There
are five classes of Hdac proteins: I, IIa, IIb, III and IV (reviewed by Thiagalingam et al.,
2003). Class I includes Hdacs 1, 2, 3 and 8 and these enzymes are expressed in most
tissues. Hdacs 1 and 2 are members of several repressive complexes including Sin3,
CoREST, NuRD and PRC2. Hdacs 4, 5, 7 and 9 comprise the class IIa subfamily of
Hdacs. Class IIa Hdacs exhibit minimal deacetylase activity in vivo and in vitro due to
evolutionary divergence of a critical tyrosine residue within the catalytic pocket. These
Hdacs are characterized by a highly conserved Mef2-binding domain. In addition, class
IIa Hdacs act as signal integrators through interactions with 14-3-3 chaperone proteins
to facilitate shuttling in and out of the nucleus. Class III sirtuins require NAD+ for
deacetylation activity and have been studied in the context of cardiac hypertrophy.
Hdac11 is the sole member of class IV Hdacs and is expressed in the heart, however its
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function remains poorly described. Of particular to our work, Hdac3 regulates cell fate in
both neural crest and cardiac development (Lewandowski et al., 2014; Singh et al.,
2011a).

Hdac3

Hdac3 is expressed in both the premigratory neural crest and cardiac progenitor
cells during development. Germline deletion leads to lethality during gastrulation, before
the neural crest is induced or the heart is formed (Bhaskara et al., 2008). Tissue-specific
knockouts have provided insight into Hdac3 function in hematopoietic progenitors, neural
crest and CPCs (Lewandowski et al., 2014; Singh et al., 2011a; Summers et al., 2013).
Loss of Hdac3 in premigratory neural crest results in embryonic lethality and abnormal
contribution to the developing outflow tract (Singh et al., 2011a). Neural crest cells
migrate to developing aortic arch arteries and differentiate into smooth muscle cells,
ensuring appropriate patterning of the outflow tract. Previous work from the Epstein lab
demonstrated that loss of Hdac3 results in deficient vascular smooth muscle and
congenital outflow tract defects including double outlet right ventricle and aortic
coarctation, due in part to decreased Notch signaling.

CPC-specific deletion of Hdac3 results in embryonic lethality late in gestation and
ventricular hypoplasia (Lewandowski et al., 2014). Hdac3 acts as a repressor of Tbx5, a
known driver of cardiogenesis which also plays critical roles in development of the
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cardiac conduction system and atrial septation (Li et al., 1997; Wamstad et al., 2012).
Through deacetylation of Tbx5, Hdac3 prevents expression of cardiomyocyte-specific
genes, promoting a thin myocardial phenotype. Cardiomyocyte-specific deletion of
Hdac3 during mid-late gestation with the alpha-myosin heavy chain Cre (aMHC-Cre)
permits survival until 3-4 months of age, when mice succumb to severe cardiac
hypertrophy and fibrosis (Montgomery et al., 2008). Interestingly, work from the Epstein
and Lazar labs demonstrated that deleting Hdac3 in postnatal myocardium and skeletal
muscle with myosin creatine kinase Cre (MCK-Cre) results in a very mild phenotype and
no lethality unless the mice are stressed by a high fat diet (Sun et al., 2011). Switching
the mice from normal chow to a high fat diet results in severe hypertrophic
cardiomyopathy and fibrosis followed by lethality of all animals within several weeks.
Myocardial Hdac3 inactivation causes extensive metabolic dysregulation of lipid and
glucose processing. Consistent with these findings, Hdac3 is unique among Hdacs for its
interaction with the NCoR-SMRT co-repressor complex that has been previously
implicated in metabolic regulation (Codina et al., 2005; Guenther et al., 2001; Sun et al.,
2012).

Hdac3 is also a potent regulator of cell proliferation and directly regulates p21.
Previous work in cancer cells and hematopoiesis linked Hdac3 to cell cycle progression
and DNA replication (Summers et al., 2013; Zeng et al., 2006). Transgenic
overexpression of Hdac3 in cardiomyocytes causes increased proliferation and
ventricular hyperplasia (Trivedi et al., 2008). Expression analysis indicated that Hdac3
represses several cyclin-dependent kinase inhibitors, reducing levels of these cell cycle
checkpoints and promoting rapid proliferation of cardiomyocytes.
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Recent work from the Lazar group has raised the intriguing possibility that Hdac3
functions as a transcriptional repressor in a deacetylase-independent manner. While
liver-specific deletion of Hdac3 results in severe hepatosteatosis, re-introduction of a
mutant form of Hdac3 lacking deacetylase activity is able to rescue most of the
functional and transcriptional deficiency (Sun et al., 2012, 2013). Furthermore, global
loss of detectable Hdac3 enzymatic activity does not result in any overt developmental
phenotype (You et al., 2013). This surprising finding stands in stark contrast to the early
embryonic lethality associated with germline knockout of Hdac3 (Bhaskara et al., 2008).
Given the previous studies connecting Hdac3 to cardiac development and emerging
evidence for a non-deacetylase function of Hdac3, it is possible that Hdac3 serves as a
regulator of progenitor cell commitment in a deacetylase-independent manner.

Chromatin architecture

An emerging level of epigenetic regulation is the spatial orientation and threedimensional structure of chromatin (reviewed by Van Bortle and Corces, 2013; Li and
Reinberg, 2011; Meister et al., 2011). Dense, heterochromatic regions are associated
with repressed gene activity and euchromatic regions with a more open conformation
permit increased access by transcription factors to the DNA and are associated with
increased gene transcription. Regulating higher order chromatin structure in this way
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allows for simultaneous control of large genomic regions and coordination of gene
expression–a requirement for large-scale processes such as cell differentiation and
stress response. For example, epigenetic mapping has demonstrated that as cells exit
pluripotency during development and become more lineage-restricted, levels of
heterochromatin increase and the genome becomes more compact while cell fates
stabilize (Paige et al., 2012).

Genome-nuclear lamina interactions

New insight into chromatin organization within the interphase nucleus has made
it clear that the localization of genes within the nucleus can affect gene expression.
Several recent studies have revealed, for example, that the conformation of chromatin at
the nuclear periphery versus in the nucleoplasm is very different (Bickmore and van
Steensel, 2013; Pickersgill et al., 2006). The inner surface of the nuclear membrane is
coated by a thin layer of intermediate filament proteins called lamins. Chromatin found at
the nuclear lamina, lamina associated domains (LADs), tends to be transcriptionally
silent and forced tethering of reporter genes to the nuclear periphery results in
repression (Reddy et al., 2008). Genome-wide mapping studies have revealed that the
organization of chromatin at the nuclear lamina versus the interior of the nucleus is
dynamic and varies over the course of cell differentiation (Peric-Hupkes et al., 2010).
The significance of these changes during development is still a matter of intense study;
however, it is clear that several diseases with cardiac manifestations are caused by
mutations in nuclear lamina-associated proteins. These laminopathies include
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Hutchinson-Gilford progeria syndrome and Emery-Dreifuss muscular dystrophy and are
due to mutations in genes encoding Lamin A and its interacting protein Emerin,
respectively (Ho et al., 2013; Shin et al., 2013). While these diseases are caused by
disruptions of the nuclear lamina, further study is required to establish whether changes
in chromatin organization are responsible for the observed phenotypes.

Hdacs and LADs

Regions of chromatin in lamina associated domains are typically decorated with
repressive histone marks and contain genes that are transcriptionally silent (Bickmore
and van Steensel, 2013; Guelen et al., 2008). Additionally, epigenetic complexes
including NuRD and NCoR-SMRT are found at the nuclear periphery, suggesting that
these complexes may function to repress lamina-bound chromatin (Berk et al., 2014;
Demmerle et al., 2012; Pegoraro et al., 2009). To determine whether the Hdacs within
these complexes are responsible for silencing genes within LADs, Nurminsky and
colleagues analyzed the effect of Hdac1 or Hdac3 knockdown on chromatin attachment
to the lamina and subsequent gene expression (Milon et al., 2012). Analysis in
Drosophila S2 cells demonstrated that Hdac1 is responsible for deacetylation and gene
repression of genes within LADs, while Hdac3 primarily acts as a tether, retaining
chromatin at the lamina. This finding is supported by work from Reddy and Singh,
demonstrating that in a complex with a BTB domain-containing transcription factor and a
lamina-bound anchor protein, Hdac3 facilitates the tethering of LADs to the nuclear
periphery in mammalian cells (Zullo et al., 2012). When combined with mapping studies
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showing dynamic movement of LADs during ESC differentiation, it is possible that Hdacs
regulate LADs to help modulate lineage-critical gene expression and influence
progenitor cell commitment (Figure 1.3 and Peric-Hupkes et al., 2010).

Conclusions

Understanding the control mechanisms underlying progenitor cell fate decisions
is important for identifying the factors critical for normal development and mapping the
systems disrupted in disease. In the neural crest and cardiac progenitor populations,
epigenetic regulators offer the ability to coordinate expression of dozens of target genes
at critical time points, ensuring appropriate expansion and differentiation. Hdac3 has a
canonical repressive function as a modifier of histone proteins; however, recent work
suggests a deacetylase-independent activity. Emerging clues from the literature suggest
that Hdac3 may regulate gene positioning and nuclear architecture, however the role of
this non-canonical function in progenitor cell biology remains unclear.
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Figure 1.1: Hierarchy of hematopoietic precursor commitment

22

Figure 1.1: Hierarchy of hematopoietic precursor commitment
Schematic of hematopoietic precursor cell commitment from self-renewing, multipotent
hematopoietic stem cells (HSC) to multipotent progenitors (MPP) to common lymphoid
progenitors (CLP) and common myeloid progenitors (CMP). These cells commit to
specific lineages as granulocyte–macrophage progenitors (GMP), megakaryocyte
erythroid progenitors (MEP), megakaryocyte progenitors (MkP) and T-cell natural killer
cell progenitors (TNK). This hierarchy serves as a model for progenitor cell commitment
in several other tissues including neural crest and cardiac progenitors. Adapted from
Robb, 2007.
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Figure 1.2: Hierarchy of cardiac precursor commitment
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Figure 1.2: Hierarchy of cardiac precursor commitment
Schematic of in vitro cardiac precursor cell commitment from self-renewing, pluripotent
embryonic stem cells (ESC) to cardiac mesoderm marked by Mesp1 expression to first
heart field (FHF) and second heart field progenitors (SHF). These cells commit to
specific lineages as cardiomyocytes (CM), smooth muscle cells (SMC) and endothelial
cells (Endo). Adapted from Robb, 2007.
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Figure 1.3: Hdac3 complexes with cKrox and Lap2β to mediate transcriptional
silencing of Lamina-associated domains (LADs)
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Figure 1.3: Hdac3 complexes with cKrox and Lap2β to mediate transcriptional
silencing of Lamina-associated domains (LADs)
Accumulation of HDACs and other transcriptional repressors at the nuclear lamina
creates a “silencing environment” responsible for low expression levels of genomic loci
positioned at the nuclear periphery. Hdac3 complexes with transcription factor cKrox and
lamina-associated protein Lap2β to maintain certain lamina-associated domains (LADs)
at the nuclear periphery and repressing genes contained within these regions as
schematized by a transcriptional start site (TSS). Adapted from Zullo et al., 2012.
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Chapter 2: Murine craniofacial development requires Hdac3-mediated repression
of Msx gene expression
The work described in this chapter was published in Developmental Biology in
conjunction with Nikhil Singh (Singh et al., 2013).

Summary

In Chapter 1, I introduced the neural crest as a progenitor cell population
emerging from the dorsal neural tube that gives rise to smooth muscle, melanocyte,
bone, cartilage and neuronal derivatives throughout the body. Hdac3 is an epigenetic
modifier that typically functions as a repressor to silence transcriptional activity. Previous
work has described the role of Hdac3 in cardiac neural crest differentiation into aortic
arch artery smooth muscle, however the role of Hdac3 in other neural crest
subpopulations remains unclear (Singh et al., 2011a). In this chapter I describe the role
of Hdac3 in neural crest patterning of craniofacial structures. Mice in which Hdac3 has
been conditionally deleted in premigratory neural crest demonstrate fully penetrant
craniofacial abnormalities, including microcephaly, cleft secondary palate and dental
hypoplasia. Consistent with these abnormalities, I show dysregulation of cell cycle genes
and increased apoptosis in neural crest structures in mutant embryos. Known regulators
of cell cycle progression and apoptosis in neural crest, including Msx1, Msx2 and Bmp4,
are upregulated in Hdac3-deficient cranial mesenchyme. These results suggest that
Hdac3 serves as a critical regulator of craniofacial morphogenesis, in part by repressing
core apoptotic pathways in cranial neural crest cells.
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Introduction

As I introduced in Chapter 1, vertebrates are unique among metazoans in their
reliance on neural crest cells to form a wide array of head structures. These neural crestderived craniofacial components are analogous to mesodermally- and ectodermallyderived structures in invertebrates (Gans and Northcutt, 1983). In midgestation in the
mouse, neural crest cells populate the pharyngeal arches – a series of paired
outpouchings that flank the developing pharynx, as well as the frontonasal prominence,
an area that eventually gives rise to the nose and forehead. The first pharyngeal arch,
which is the largest and most rostral of the arches, contains the neural crest cells that
will form structures in the face and neck (Alappat et al., 2003). Driven by the proliferation
and continued influx of migrating neural crest cells, two distinct outgrowths arising from
the first arch, known as the maxillary and mandibular prominences, grow ventrally and
flank the developing oropharynx, eventually fusing at the ventral midline in what
becomes the face. Failure of neural crest cells to migrate or proliferate appropriately can
result in hypoplasia of these structures and the absence of fusion, which can manifest as
abnormal facies and clefting (Ito et al., 2003; Vallejo-Illarramendi et al., 2009).

In addition to appropriate proliferation and migration, neural crest patterning
depends upon carefully controlled apoptosis of premigratory crest cells. In the
developing hindbrain, a premigratory neural crest population arises in each of eight
rhombomeres. However, the majority of neural crest cells in rhombomeres 3 and 5
undergo apoptosis, and the few surviving cells make small contributions to the discrete
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streams of migrating neural crest that populate and pattern the developing pharyngeal
arches (Graham et al., 1993; Sechrist et al., 1993; Birgbauer et al., 1995; Köntges et al.,
1996; Ellies et al., 2002). Loss of this selective apoptosis through ablation of
rhombomere 4 causes increased survival and migration of crest cells from rhombomeres
3 and 5, resulting in ectopic muscle attachment sites on the developing mandible (Ellies
et al., 2002). A signal for selective apoptosis of neural crest cells specifically in these two
rhombomeres is induced by increased expression of Msx2 (Graham et al., 1994). A
related member of this muscle segment homeobox family of genes, Msx1, is also a
proapoptotic factor in neural crest cells and controls programmed cell death by
regulating several caspases in the apoptotic pathway (Tríbulo et al., 2004).

Several human syndromes have implicated MSX genes in craniofacial
development. Some patients with autosomal-dominant Boston-type craniosynostosis
harbor a missense mutation in MSX2 and present with a variety of malformations
including abnormal skull shape and cleft palate (Warman et al., 1993; Jabs et al., 1993).
Additionally, deletion of the MSX1 gene in patients with Wolf-Hirschhorn syndrome
manifests with a spectrum of ear, tooth, and skull defects (Ivens et al., 1990). These
disorders highlight the critical role that Msx factors play in regulating how the neural
crest contributes to the derivative structures that make up the calvaria and face.

Murine genetics have also proven invaluable in deciphering the genetic programs
that coordinate the proliferation, migration and apoptosis of cranial neural crest cells. For
instance, models of conditional deletion and overexpression of Msx1 and Msx2 have
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further delineated roles for these molecules in various aspects of craniofacial
development. Msx1 has been studied extensively in the developing tooth and is highly
expressed in neural crest-derived dental mesenchyme, where it is required for proper
condensation and development of the molar tooth germ beyond the bud stage (Satokata
et al., 1994; Chen et al., 1996). Deletion of the Msx1 gene in mice results in reduced
Bmp4 expression in the dental mesenchyme, supporting the well-studied interaction of
Msx genes and Bmp4 (Graham et al., 1994; Chen et al., 1996; Bei et al., 2000). In
addition to its role in neural crest patterning and apoptosis in the developing hindbrain
(Graham et al., 1993, 1994), Msx2 also regulates osteogenesis and functions with Msx1
to control cranial neural crest differentiation into bones of the calvaria (Han et al., 2007;
Roybal et al., 2010). Interestingly, both overexpression and inactivation of Msx2 causes
defects in calvaria and tooth development (Dodig et al., 1999; Satokata et al., 2000),
suggesting that the Msx1/Msx2 apoptotic pathway must be exquisitely regulated during
craniofacial development.

While neural crest proliferation and localized apoptosis are critical for normal
craniofacial morphogenesis, little is known about how the pathways controlling these
processes are regulated at the epigenetic level. In this chapter, I demonstrate that the
class I histone deacetylase Hdac3 regulates genetic programs involved in murine
craniofacial development. Global deletion of Hdac3 results in lethality prior to E9.5
(Bhaskara et al., 2008). Conditional genetic deletion of Hdac3 in neural crest results in
cleft palate, hypoplastic teeth and a variety of defects in calvarial structures of neural
crest origin. Loss of Hdac3 leads to upregulation of established mediators of neural crest
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apoptosis, including Msx1, Msx2 and Bmp4. These results suggest that Hdac3-mediated
repression of Msx signaling plays a critical role in craniofacial development.
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Results

Hdac3 is widely expressed during craniofacial development and is efficiently
deleted in neural crest derivatives by Wnt1-Cre

In order to explore the epigenomic regulation of craniofacial development, we
deleted the class I histone deacetylase Hdac3 in premigratory neural crest cells using
the Wnt1-Cre transgene and a floxed Hdac3 allele (Hdac3f) (Jiang et al., 2000; Mullican
et al., 2011). Using the Z/EG reporter allele (Novak et al., 2000), we observed that both
Wnt1-Cre; Hdac3f/f (which we have termed Hdac3Wnt1NCKO); Z/EG and Wnt1-Cre; Z/EG
control embryos demonstrate intact migration of neural crest cells into the developing
face and pharyngeal arch region at E9.5 (Figure 2.1A, Figure 2.2).
Immunohistochemistry of staged embryos demonstrates that Hdac3 is widely expressed
in the developing head at E9.5 and E10.5, including in neural crest, ectoderm and
endoderm (Figure 2.1B and data not shown). Expression of PlexinA2, a neural crest
marker (Brown et al., 2001), appears unaltered in Hdac3 mutant embryos at E9.5
(Figure 2.2), further indicating that neural crest migration is normal at this stage. In
Hdac3Wnt1NCKO embryos, Hdac3 protein expression is lost in neural crest-derived
craniofacial mesenchyme, while expression is retained in ectoderm and endoderm
(Figure 2.1B). In the absence of neural crest expression of Hdac3, the maxillary and
mandibular prominences of the first pharyngeal arch demonstrate mild hypoplasia as
early as E10.5 (Figure 2.1B,C). This is in contrast to the caudal pharyngeal arches,
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which demonstrate no hypoplasia at E10.5 in the absence of Hdac3 expression (Singh
et al., 2011).

Hdac3Wnt1NCKO embryos exhibit severe craniofacial abnormalities in late gestation,
resulting in perinatal lethality

Embryos in which Hdac3 is deleted in neural crest cells are found at expected
Mendelian ratios in late gestation and are viable until birth, but uniformly succumb at P0
(Singh et al., 2011). Hdac3Wnt1NCKO mice are born with microcephaly, micrognathia, a
shortened snout and eyelid closure defects, with preservation of body morphology
(Figure 2.3A). Optical projection tomography and histology of Hdac3Wnt1NCKO P0 heads
reveals cleft palate, which is also apparent in late gestation embryos (Figure 2.3B,C).
The palate defect is characterized by a large posterior cleft, without additional facial
clefting (Figure 2.3B). Cleft palate is fatal in perinatal mice; afflicted pups are unable to
generate suction and nurse, and subsequently die at P0 from dehydration and
accumulation of air in the digestive tract (Condie et al., 1997; Qiu et al., 1995).
Consistent with these reports, Hdac3Wnt1NCKO pups are unable to feed, as evidenced by
the lack of a milk spot (Figure 2.3A). The gross craniofacial defects observed in
Hdac3Wnt1NCKO mice are fully penetrant and are summarized in Table 2.1. We observed
similar craniofacial abnormalities using a second neural crest driver, Pax3Cre (Engleka et
al., 2005); these abnormalities are also fully penetrant both at P0 and in late gestation
(Figure 2.4 and data not shown).
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Loss of Hdac3 in neural crest leads to bone defects in the calvaria and
viscerocranium

In the adult vertebrate, osteoblasts are among the most abundant cell types
generated by cranial neural crest. These neural crest-derived osteoblasts contribute to
the bones of the face, the skull base and the entirety of the calvaria, with the exception
of the parietal bone (Santagati and Rijli, 2003). Hdac3 has previously been implicated in
multiple stages of osteoblast differentiation and maturation. In committed,
undifferentiated osteoblasts that express the Osx-Cre transgene, deletion of Hdac3
leads to subtle abnormalities in calvarial osteoblast differentiation, and progressive
abnormalities in trabecular bones that lead to perinatal runting and death early in
adulthood (Razidlo et al., 2010).

Consistent with a pro-osteogenic role for Hdac3 at the earliest stages of bone
development in neural crest, Hdac3Wnt1NCKO mice - in which Hdac3 is deleted prior to
osteoblast specification (before the onset of Osx-Cre expression) - exhibit severe bone
defects in the calvaria and viscerocranium (Figure 2.5). Alcian blue/alizarin red staining
of the late embryonic and perinatal mice reveals decreased ossification of the calvaria,
particularly in the region of the frontal bone, where ossified bone is nearly undetectable
by alizarin red staining (Figure 2.5A). The open frontal fontanel leads to hemorrhage in
some newborn pups following parturition (Figure 2.5B). The parietal bone develops
normally in Hdac3Wnt1NCKO mutants, consistent with its mesodermal origin (Figure 2.5A).
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In mutant embryos, ossification abnormalities of the viscerocranium were also identified
in the mandible, skull base, and tympanic ring (Figure 2.5A).

Additional bone abnormalities in E17.5 mutant embryos are detectable by
Goldner’s trichrome staining. Neural crest-derived calvarial bones, including the frontal
bone, are thin and show minimal mineralization (Figure 2.5B). Additionally, at variable
penetrance, absence of ossification in the sphenoid bone plate results in
encephalocoele, in which the brain herniates into the nasal sinuses (Figure 2.5B). The
bone defects observed in Hdac3Wnt1NCKO mice are summarized in Table 2.1.

To establish whether loss of Hdac3 in the developing calvaria affects migration
and survival of neural crest, or differentiation of osteogenic precursors, we fate mapped
cranial crest cells to the E12.5 calvaria using the Z/EG reporter, measured apoptosis
with TUNEL staining and evaluated pre-osteoblast differentiation by Runx2
immunohistochemistry (Figure 2.6). We observed that mutant cranial crest exhibit
normal migration to the calvaria and normal expression of the critical ossification
regulator Runx2 at the frontal bone primordium (Ishii et al., 2003), but demonstrate
increased apoptosis compared to controls. These observations suggest that the bone
abnormalities in the Hdac3Wnt1NCKO mice are associated with decreased survival of neural
crest cells, and are unlikely to be due to a primary abnormality in differentiation or
migration.

36

Hdac3 is required for normal odontogenesis

Seminal work in amphibians and avian models established that the cranial neural
crest makes up a significant portion of the developing tooth, specifically the dental
mesenchyme (LeDouarin, 1982; reviewed by Maas and Bei, 1997). Further studies in
mouse demonstrate that patterning of the developing molar tooth germ is influenced by
the interaction of the epithelium and mesenchyme. Recombination experiments with
neural crest and epithelium revealed that early (E9.5-12.0) oral epithelium can signal to
non-dental mesenchyme to form teeth; however, later in development, the dental
mesenchyme possesses odontogenic potential to induce non-oral epithelium to become
enamel (Kollar et al., 1969; Mina et al., 1987; Lumsden 1988).

In murine tooth development, signals from the epithelium initiate condensation of
neighboring mesenchyme composed of neural crest cells at E11.5 (Chen et al., 2000).
As epithelial cells invaginate, they envelop neural crest cells, which will eventually form
the pulp of the tooth (Figure 2.7A). In Hdac3Wnt1NCKO embryos, the early stages of
odontogenesis proceed normally, with tooth bud morphology at E15.5 appearing similar
to littermate controls through the bud and cap stages (Figure 2.7A-D). However,
expansion of the neural crest-derived mesenchyme does not occur between E15.5E17.5, resulting in hypoplastic teeth with the absence of normal pitting (Figure 2.3C and
Figure 2.7E,F). The tooth bud hypoplasia in mutant embryos parallels the hypoplasia
observed in other neural crest-derived structures in late gestation (Figure 2.3).
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Aberrant cell cycle regulation in Hdac3-deficient cranial mesenchyme leads to a
failure of neural crest cell expansion, dental hypoplasia and cleft palate

In order to further delineate the mechanism by which deletion of Hdac3 results in
hypoplasia of neural crest structures, we performed a histological analysis of staged
control versus Hdac3Wnt1NCKO embryos. In normal palatogenesis, the anterior palate is
formed by fusion of the maxillary prominence with the frontonasal prominence.
Hdac3Wnt1NCKO embryos exhibit posterior cleft palate, suggesting that secondary
palatogenesis is disrupted (Figure 2.3B). The posterior aspects of the hard palate
(referred to as the secondary palate) are formed from two outgrowths of neural crestderived mesenchyme that lie on either side of the stomodeum. These outgrowths - the
palatal shelves - are detectable at E11.5 in the mouse at both anterior and posterior
levels (Figure 2.8A,A’). Between E11.5 and E13.5, the palatal shelves, driven by neural
crest cell proliferation, expand towards the mandible (Figure 2.8A,A’,B,B’). Between
E13.5 and E14.5 the palatal shelves elevate relative to the tongue and fuse in the
midline with the nasal septum (Figure 2.8C,C’). This newly formed structure
subsequently ossifies, giving rise to the mature secondary palate (Figure 2.8D,D’).

Disruption of any of the stages of secondary palatogenesis - palatal shelf
formation, expansion, elevation, fusion or ossification – can lead to cleft palate in mice,
and similar mechanisms are believed to contribute to secondary cleft palate in humans
(He et al., 2011; Ito et al., 2003; Richarte et al., 2007; Vallejo-Illarramendi et al., 2009;
Wu et al., 2008). Histological analysis of Hdac3Wnt1NCKO embryos reveals that the palatal
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shelves form appropriately but are hypoplastic at E12.5 (Figure 2.8E,E’,F,F’). Despite
appropriate elevation of the medial aspect of the palatal shelves by E14.5, the palatal
shelves do not meet at the midline (Figure 2.8G,G’). These results suggest that cleft
palate in Hdac3Wnt1NCKO embryos is due to a failure of palatal shelf expansion.

Expansion of the palatal shelves is dependent upon proliferation and survival of
the neural crest cells that make up the palatal shelf mesenchyme (Ito et al., 2003). In
E12.5 mutant versus control palatal shelves that were matched for surrounding
anatomical landmarks, we detected a significant increase in apoptosis and a trend
towards decreased proliferation, as determined by TUNEL and phospho-histone H3
staining, respectively (Figure 2.8I). Increased TUNEL staining is also visible throughout
additional cranial neural crest-derived structures outside of the palatal shelf region
including the tooth bud and calvaria, suggesting that hypoplasia of these structures is
also mediated by increased apoptosis (Figure 2.6, Figure 2.8I, Figure 2.9E).

To discern the nature of the cell cycle dysregulation in Hdac3Wnt1NCKO cranial
mesenchyme, we performed expression profiling by quantitative RT-PCR of
microdissected anterior cranial tissue of E12.5 mutant embryos and littermate controls
(Figure 2.9A). While Hdac3 expression in mutant tissue is significantly downregulated,
expression of the other class I Hdacs is unchanged (Figure 2.9B). Strikingly, the
expression of multiple cell cycle regulators is altered in Hdac3Wnt1NCKO cranial
mesenchyme. Cdkn1a (p21), Trp53 (p53), Cdkn1c (p57), Ccnd1 (Cyclin D1), Ccnd3
(Cyclin D3), CcnG1 (Cyclin G1) and Cdk2 are significantly upregulated in the absence of
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Hdac3, while Cdkn2c (p18) expression is downregulated (Figure 2.9C). This pattern of
gene dysregulation is consistent with G1/S arrest of neural crest cells.

Hdac3 has previously been shown to directly repress the cell cycle inhibitor gene
Cdkn1a (p21) in multiple tissues (Trivedi et al., 2008; Wilson et al., 2008). In order to
determine whether the substantial upregulation of Cdkn1a observed in Hdac3Wnt1NCKO
cranial mesenchyme is sufficient to account for cleft palate and microcephaly in these
embryos, we deleted Hdac3 in neural crest on a Cdkn1a null background (Deng et al.,
1995). Homozygous Cdkn1a-/- mice develop normally and are viable and fertile (Deng et
al., 1995). We found that loss of p21 does not rescue the cleft palate and microcephaly
observed in Hdac3Wnt1NCKO embryos, suggesting that dysregulation of additional cell
cycle modulators contributes to altered regulation of neural crest expansion in Hdac3deficient cranial neural crest cells, and ultimately to cleft palate and craniofacial
hypoplasia (Figure 2.10).

The loss of Hdac3 results in dysregulation of core networks that regulate
craniofacial development
In multiple aspects of embryogenesis, including neural crest development and
limb development, the homeobox transcription factors Msx1 and Msx2 and the signaling
molecule Bmp4 function to initiate apoptosis (Barlow and Francis-West, 1997; Graham
et al., 1994; Lallemand et al., 2005; Marazzi et al., 1997). Msx1 is expressed in the
palatal shelves and dental mesenchyme, and regulates development of these neural
crest-derived structures (Satokata et al., 1994; Chen et al., 1996; Maas and Bei, 1997;
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Bei et al., 2000; Alappat et al., 2003). Msx2 is expressed in the early dental
mesenchyme and is also crucial for normal tooth development (Maas and Bei, 1997;
Winograd et al., 1997). Bmp4 is primarily expressed by epithelial structures in the
developing face, which signal to neural crest-derived mesenchyme to mediate processes
such as palatogenesis and odontogenesis, and its expression can be induced by Msx
genes in neural crest derivatives (Zhang et al., 2002, Mitsiadis et al., 2010).

We measured the expression of important regulatory genes involved in
craniofacial development using a candidate approach, and detected significant
upregulation of Msx1, Msx2 and the target gene Bmp4 in the anterior cranial
mesenchyme of E12.5 Hdac3Wnt1NCKO embryos, but found no significant differences in
the expression of palate-specific markers Osr2 and Shox2 (Figure 2.9D, Figure 2.11)
(Lan et al., 2004; Yu et al., 2005). In situ hybridization reveals substantially more
expression of Msx1 transcripts in the dental mesenchyme of mutant embryos than in
littermate controls (Figure 2.9E). We also observe increased expression of Msx1 in the
developing palatal shelves of Hdac3-deficient embryos compared to littermate controls
(Figure 2.9F). Similar to Msx1, in situ hybridization for Msx2 shows elevated expression
specifically in the dental mesenchyme of E12.5 Hdac3Wnt1NCKO embryos (Figure 2.9E).

Interestingly, transgenic overexpression of Msx2 leads to cleft secondary palate,
skull malformations, micrognathia, tooth hypoplasia and eyelid dysplasia, which
phenocopies many aspects of the Hdac3Wnt1NCKO abnormalities (Winograd et al., 1997).
Gain of BMP signaling also results in craniofacial abnormalities that partially phenocopy
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the abnormalities identified in Hdac3Wnt1NCKO embryos (He et al., 2010). These
observations suggest that the hypoplasia of neural crest-derived structures observed in
Hdac3Wnt1NCKO embryos may be in part mediated by derepression of Msx1 and Msx2
leading to increased apoptosis (Graham et al., 1994; Tríbulo et al., 2004; Park et al.,
2005). Consistent with this hypothesis, we observed increased apoptosis in Hdac3
mutants in dental mesenchyme and palatal shelves, coincident with increased Msx
expression (Figure 2.9E,F).

To determine whether Msx gene upregulation has a functional role in mediating
the observed cell cycle dysregulation and failure of neural crest structures to expand
during development, we performed siRNA-mediated knockdown of Msx1 or Msx2,
individually or in combination, in cultured neural crest mesenchyme from control and
Hdac3Wnt1NCKO embryos. We observed a partial restoration of wild-type levels of neural
crest proliferation following knockdown of either Msx1 or Msx2 (Figure 2.12). Taken as a
whole, these results suggest that derepression of Msx1 and Msx2 in the absence of
Hdac3 causes decreased proliferation and increased apoptosis in cranial neural crest
cells, manifesting as abnormal facies, cleft palate, dental hypoplasia and bone
deficiencies.

In addition to the Msx gene products, the T-box transcription factors Tbx2 and
Tbx3 have been shown to play significant roles in palate expansion and neural crest
development (Zirzow et al., 2009; Mesbah et al., 2012). Tbx2 and Tbx3, like Msx1 and
Msx2, are normally expressed in neural crest-derived cranial mesenchyme and are
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important in cell cycle regulation during palatogenesis (Zirzow et al., 2009). Loss of Tbx2
or Tbx3 in craniofacial development leads to cleft palate due to excessive proliferation,
and both proteins have been identified as inhibitors of the cell cycle in palatogenesis
(Zirzow et al., 2009). We observe significant upregulation of these members of the T-box
transcription factor family in Hdac3-deficient craniofacial mesenchyme, consistent with
the observed cell cycle dysregulation in neural crest-derived tissue (Figure 2.9D).
Overall, the pattern of upregulation of these Msx, T-box transcription factors, cell cycle
regulators and the signaling molecule Bmp4 – all known inhibitors of neural crest
survival - is consistent with a model in which Hdac3 represses core inhibitors of the
neural crest cell cycle in order to drive craniofacial development.
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Discussion

At multiple stages of neural crest development, the growth and survival of neural
crest cells comes under positive and negative regulation from surrounding cell types, but
is also subject to cell autonomous regulation (Sauka-Spengler and Bronner-Fraser,
2008). The homeodomain transcription factors Msx1 and Msx2 are important mediators
of neural crest apoptosis in both early and late stages of craniofacial morphogenesis, but
the temporal and spatial regulation of their expression is poorly understood.
Interestingly, both increased and decreased Msx gene levels in developing neural crest
lead to severe craniofacial abnormalities (Bei and Maas, 1998; He et al., 2010). That
craniofacial morphogenesis is so exquisitely sensitive to Msx expression speaks to the
importance of fine regulation of the timing and patterning of Msx1 and Msx2 transcription
during neural crest development.

In this chapter, I demonstrate that loss of Hdac3 in neural crest results in severe
craniofacial malformations including microcephaly, cleft palate, impaired bone formation
in the skull and hypoplasia of the teeth. Inactivation of Hdac3 by Wnt1-Cre results in cell
cycle dysregulation in neural crest-derived structures, including increased expression of
p21, p53, p57, Cyclin D1, Cyclin D3, Cyclin G1 and Cdk2. Hdac3Wnt1NCKO embryos exhibit
elevated expression of Msx1 and Msx2 in the anterior cranial mesenchyme, and
knockdown of Msx1 and Msx2 in mutant tissue partially normalizes neural crest
proliferation. Incomplete rescue in this assay may have been due to incomplete
knockdown of Msx1 and Msx2 using siRNA approaches, but may also suggest that
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factors other than Msx1 and Msx2 are functionally altered in Hdac3 mutants and
contribute to the cell cycle dysregulation that we observe. Indeed we observe
upregulation of Tbx2 and Tbx3 in Hdac3-deficient cranial mesenchyme, and abnormal Tbox factor expression is also likely to contribute to the abnormal phenotype in
Hdac3Wnt1NCKO mice. Dysregulation of Tbx factors and other regulators of neural crest
development is also likely to explain the strong – but not complete – overlap between the
phenotype of Hdac3Wnt1NCKO mice and Msx2 transgenic overexpressing mice (Winograd
et al., 1997).

Previous work investigating the regulation of Msx1 transcription in cell lines
identified several regulatory elements in the Msx1 upstream genomic region (Takahashi
et al., 1997). LacZ reporters of a “minimal” Msx1 promoter containing these regulatory
regions were strongly expressed in the neural crest-derived anterior cranial
mesenchyme of E12.5 embryos (Takahashi et al., 1997). Similar work with the Msx2
promoter region has also identified highly conserved enhancers that contribute to Msx2
expression in the craniofacial mesenchyme when fused to lacZ reporters (Liu et al.,
1994). In light of the canonical role of Hdac3 as a transcriptional repressor, it is
reasonable to hypothesize that Hdac3 may directly repress Msx1 and Msx2 expression
in neural crest by deacetylating histones at these promoters/enhancers, either at known
or novel regulatory regions. However, my in vivo chromatin immunoprecipitation
experiments have not demonstrated Hdac3 occupancy of previously described enhancer
regions (Brugger et al., 2004; Hussein et al., 2003). As a global modulator of gene
expression, Hdac3 is likely to affect the expression of multiple pathways involved in
craniofacial development. Additional work is needed to determine whether Hdac345

mediated repression of Msx1 and Msx2 occurs via histone deacetylation at
uncharacterized enhancer regions at these loci, through derepression of additional
intermediate genes or via direct deacetylation of non-histone targets. Interestingly,
recent results suggest that critical functions of Hdac3 in the embryo are independent of
its interactions with NCOR1 and SMRT, co-repressors that are necessary for Hdac3
catalytic activity (You et al., 2013). Thus, Hdac3 may mediate important developmental
processes through a non-canonical function unrelated to deacetylation of histone
targets.

My finding of decreased bone formation in Hdac3 conditional mutants is
consistent with the pro-ossification role that Hdac3 is known to play in osteoblast
precursors; however, by deleting Hdac3 prior to the specification and expansion of
osteoblast precursors, we observe drastic deficiencies in bone formation not seen after
deletion of Hdac3 in committed Osx-expressing cells (Razidlo et al., 2010). My results
demonstrate increased apoptosis of neural crest-derived mesenchyme in the developing
calvaria, despite intact neural crest migration and normal expression of the osteoblast
regulatory molecule Runx2. Paradoxically, deletion of Msx1 and Msx2 in neural crest
leads to heterotopic bone formation, particularly in the frontal bone region, while Msx2
transgenic overexpression also results in ectopic bone formation, with decreased
mineralization in the interparietal bone (Liu et al., 1995; Roybal et al., 2010; Winograd et
al., 1997). While some of the bone abnormalities in Hdac3Wnt1NCKO embryos could be
attributed to derepression of Msx gene expression, it is likely that additional targets of
Hdac3 underlie the skeletal abnormalities in these mice. An interesting future area of
research will involve determining additional targets of Hdac3 that regulate the early
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stages of bone development in neural crest progenitor cells and additional populations of
osteoblast precursors.

47

Materials and Methods

Mice
Wnt1-Cre, Pax3Cre, Hdac3flox, Z/EG and p21 null mice were maintained on mixed
CD1/B6/129 genetic backgrounds separated by 4-8 generations of interbreeding from
pure parental strains (Engleka et al., 2005; Jiang et al., 2000; Mullican et al., 2011;
Novak et al., 2000). Mice were genotyped using previously described Cre-specific PCR
primers (5’-TGC CAC GAC CAA GTG ACA GC-3’, 5’-CCA GGT TAC GGA TAT AGT
TCA TG-3’) (Heidt and Black, 2005), and primers designed to distinguish between the
control and floxed Hdac3 allele (5’-GCA GTG GTG GTG AAT GGC TT-3’, 5’-CCT GTG
TAA CGG GAG CAG AAC TC-3’). Genotyping for the Z/EG transgene was performed by
X-Gal staining tail samples. Littermate embryos were analyzed in all experiments unless
otherwise noted. The University of Pennsylvania Institutional Animal Care and Use
Committee approved all animal protocols.

Histology, immunohistochemistry and in situ hybridization

These techniques were performed on paraformaldehyde-fixed, paraffin
embedded slides as previously described (High et al., 2008). Embryos were dissected in
cold PBS, fixed overnight in 2% paraformaldehyde, dehydrated into 100% ethanol,
embedded in paraffin and sectioned. H&E and Goldner’s trichrome staining were
performed using standard procedures. Primary antibodies used for
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immunohistochemistry were anti-GFP goat polyclonal (Abcam AB6673, 1:100), anti-GFP
rabbit polyclonal (Invitrogen A-11122, 1:200), anti-Runx2 rabbit polyclonal (Santa Cruz
sc-10758 1:20), anti-phospho histone H3 rabbit polyclonal (Cell Signaling #9701 1:50)
and anti-Hdac3 rabbit polyclonal (Santa Cruz sc-11417x, 1:10). Radioactive in situ
hybridization for Msx1,Msx2 and PlexinA2 was performed as previously described
(Engleka et al., 2005). Msx1 probe corresponds to RefSeq #NM_010835 (bp 862-1741),
Msx2 to #NM_013601 (bp 159-1143) and PlexinA2 as previously described (Brown et
al., 2001). TUNEL staining was performed as previously described (Jain et al., 2011). All
control and mutant histological and immunohistochemical images shown for comparison
were taken at the same exposure and contrast settings, using NIS Elements software.
Pharyngeal arch size was quantified using ImageJ software by counting number of
pixels in at least three serial sections from control and mutant frontal sections. All
quantification was done in a blinded manner.

Cell number, proliferation and apoptosis were quantified by manually counting
nuclei, phospho histone H3-, or TUNEL-positive cells, respectively, in adjacent sections
of the anatomically-defined palatal shelf region in a blinded manner.

Optical projection tomography

Samples were dehydrated into 100% methanol, embedded in 1% low-melt
agarose, cleared overnight in 1:2 (v/v) benzyl alcohol and benzyl benzoate, and scanned
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using the Bioptonics OPT scanner (3001M) (Sharpe et al., 2002). Image stacks were
reconstructed using OsiriX software. Image contrast was optimized to show anatomic
detail.

siRNA transfection

E12.5 anterior craniofacial mesenchyme was microdissected and dissociated to
single cell suspension with 0.25% Trypsin-EDTA. Cells were incubated at 37

C in 5%

CO2 for 16 hours before transfection with 50nM control (Santa Cruz sc-37007), Msx1
(Dharmacon #M-044089-01) or Msx2 siRNA (Dharmacon #M-047845-01) using
Lipofectamine RNAiMax (Invitrogen #13778030). 24 hours after transfection, cells were
fixed with 4% paraformaldehyde (10 min, room temperature) and permeabilized with
0.2% Triton X-100. Immunocytochemistry was performed with anti-phospho histone H3
rabbit polyclonal (Cell Signaling #9701 1;100). Cell number and proliferation were
quantified by manually counting nuclei and phospho histone H3-positive cells in a
blinded manner.

Alcian blue/alizarin red staining

Neonatal mice were eviscerated and skinned after being soaked in room
temperature water for 3 hours followed by a 1 minute heat shock at 65oC to loosen the
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skin. The samples were then fixed for 3 days in 100% ethanol at room temperature.
Samples were stained for 2 days at room temperature with Alcian blue solution
(0.3mg/ml Alcian Blue, 80% ethanol, 20% acetic acid) to visualize cartilage, and then
rinsed and postfixed in 100% ethanol at room temperature, overnight. Samples were
then incubated for 24 hours with Alizarin Red solution (0.065mg/ml Alizarin Red S in
0.5% KOH) to visualize bone, followed by incubation in 0.5% KOH until soft tissues were
mostly digested. The 0.5% KOH solution was replaced with 25% glycerol in water
(added very slowly to sample) and incubated at room temperature until tissues cleared.

RNA isolation, complementary DNA synthesis and quantitative RT-PCR

For E12.5 cranial mesenchyme expression profiling, Wnt1-Cre; Hdac3f/f and
littermate Cre-negative control embryos were microdissected with tungsten needles in
cold PBS. RNA was obtained using the Qiagen RNeasy spin column, with on-column
DNAse I digestion. Complementary DNA (cDNA) was synthesized according to kit
instructions with the Superscript III system (Invitrogen). Quantitative RT-PCR was
performed in triplicate using Sybr Green (Applied Biosystems). Gapdh was used as a
reference control gene. Quantitative RT-PCR primers (Table 2.2) were designed using
IDT software.

Statistics
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The student’s two-tailed t test was used to ascertain differences between groups.
A p-value of less than 0.05 was considered significant.
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Table 2.1: Late gestation and perinatal craniofacial abnormalities in Hdac3Wnt1NCKO
mice
E16.5-P0

Wnt1-Cre

Wnt1-Cre; Hdac3f/f

Microcephaly

0% (0/20)

100% (27/27)

Cleft palate

0% (0/20)

100% (27/27)

Eyelid dysplasia

0% (0/20)

100% (27/27)

0% (0/20)

100% (27/27)

Hyoid bone

0% (0/7)

75% (6/8)

Sphenoid bone

0% (0/7)

88% (7/8)

Tympanic ring

0% (0/7)

88% (7/8)

Frontal bone

0% (0/7)

100% (8/8)

Mandible

0% (0/7)

100% (8/8)

Maxilla

0% (0/7)

100% (8/8)

Nasal bone

0% (0/7)

100% (8/8)

Orbit

0% (0/7)

100% (8/8)

Temporal bone

0% (0/7)

100% (8/8)

Zygomatic arch

0% (0/7)

100% (8/8)

Interparietal bone

0% (0/7)

100% (8/8)

Anteriorally displaced
foramen magnum
Absence of:

Hypoplasia and
incomplete mineralization
of:
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Table 2.2: Quantitative RT-PCR primer sequence information
Gene
name
Bmp4

Protein

Sequence (5’ – 3’)

Bmp4

GAGCAGAGCCAGGGAAC

Product

Genomic

size

size

138

1140

145

1538

120

1001

147

1597

128

1251

155

931

145

651

144

705

150

694

GAAGAGGAAACGAAAAGCAGAG

Ccnd1

Cyclin D1

GCCCTCCGTATCTTACTTCAAG
GCGGTCCAGGTAGTTCATG

Ccnd3

Cyclin D3

GCGTGCAAAAGGAGATCAAG
GATCCAGGTAGTTCATAGCCAG

Ccng1

Cyclin G1

CAGTTCTTTGGCTTTGACACG
TTCCTCTTCAGTCGCTTTCAC

Cdk2

Cdk2

GCATTCCTCTTCCCCTCATC
GGACCCCTCTGCATTGATAAG

Cdk4

Cdk4

TACATACGCAACACCCGTGGACAT
AGTCGTCTTCTGGAGGCAATCCAA

Cdkn1a

p21

CTTGCACTCTGGTGTCTGAG
GCACTTCAGGGTTTTCTCTTG

Cdkn1b

p27

TGGACCAAATGCCTGACTC
GGGAACCGTCTGAAACATTTTC

Cdkn1c

p57

CAGGACGAGAATCAAGAGCAG
CGACGCCTTGTTCTCCTG
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Cdkn2a

Cdkn2c

p16 Ink4a

ATCTGGAGCAGCATGGAGTC

(Trivedi et al.,
2008)

CGAATCTGCACCGTAGTTGA

p18

AAACGTCAACGCTCAAAATGG

198

5198

133

3524

138

1140

177

2011

135

4741

144

3045

142

6837

149

22619

132

2296

121

3859

GACAGCAAAACCAGTTCCATC

Cdkn2d

p19 Ink4d

CTTCATCGGGAGCTGGTG
AGGCATCTTGGACATTGGG

Gapdh

Gapdh

CGTCCCGTAGACAAAATGGT
GAATTTGCCGTGAGTGGAGT

Hdac1

Hdac1

GAGATGACCAAGTACCACAGTG
AAACAAGCCATCAAACACCG

Hdac2

Hdac2

AGAAGGAGACAGAGGACAAGA
CGAGGTTCCTAAAGTTGGAGAG

Hdac3

Hdac3

CCATTCTGAGGACTACATCGAC
TGTGTAACGGGAGCAGAAC

Hdac8

Hdac8

ACCGAATCCAGCAAATCCTC
CAGTCACAAATTCCACAAACCG

Msx1

Msx1

AAGATGCTCTGGTGAAGGC
TGGTCTTGTGCTTGCGTAG

Msx2

Msx2

CTCGGTCAAGTCGGAAAATTC
GTTGGTCTTGTGTTTCCTCAG
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Msx3

Msx3

AGTCGCGCACTCTTGTC

141

786

145

1101

131

2726

147

1054

150

1946

149

6524

TATTGCTTCTGGTGAAACTTGC

Osr2

Osr2

TTGCTCATTCACGAGAGGAC
TCCCACACTCCTGACATTTG

Shox2

Shox2

CCCACTATCCAGACGCTTTC
ACCTTTGTGAAGTTGATTTTCCTG

Tbx2

Tbx2

CACAAACTGAAGCTGACCAAC
GAAGACATAGGTGCGGAAGG

Tbx3

Tbx3

AGCCAACGATATCCTGAAACTG
GTGTCTCGAAAACCCTTTGC

Trp53

p53

AGTTCATTGGGACCATCCTG
GCTGATATCCGACTGTGACTC
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Figure 2.1: Deletion of Hdac3 in neural crest results in cranial hypoplasia at E10.5
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Figure 2.1: Deletion of Hdac3 in neural crest results in cranial hypoplasia at E10.5
(A) Gross images of E9.5 embryos visualized with direct fluorescence. Migration of
neural crest cells into the developing face and pharyngeal arch region is grossly intact in
the absence of neural crest expression of Hdac3. (B) Immunohistochemistry for GFP
and Hdac3 in frontal sections of the facial mesenchyme of E10.5 embryos. Hdac3 is
efficiently deleted in neural crest-derived cranial mesenchyme (arrowhead), as well as
the conotruncal cushions of the developing cardiac outflow tract (arrow). Note that
cranial crest-derived (GFP+) structures in the mutant are hypoplastic (open bracket). (C)
Quantification of the size of the first pharyngeal arch from serial sections of E10.5 control
and mutant embryos. Scale bars: (A): 300µm. (B): 400µm.
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Figure 2.2: Neural crest migration in Hdac3Wnt1NCKO embryos is intact at E9.5
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Figure 2.2: Neural crest migration in Hdac3Wnt1NCKO embryos is intact at E9.5
(A) Neural crest migration evaluated by PlexinA2 expression and fate mapping. (Inset
i,ii) E9.5 mutant and littermate controls demonstrate similar expression of PlexinA2, a
marker of neural crest. (Inset iii,iv) Neural crest-derived cells fate mapped by Wnt1-Cre
and the Z/EG reporter populate the first pharyngeal arch similarly in mutant and control
embryos. (B) Quantification of the area occupied by cranial crest-derived GFP+ cells in
the first pharyngeal arches of mutant and control embryos reveals no significant
difference. Scale bar: (A): 200µm.
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Figure 2.3: Craniofacial abnormalities in Hdac3Wnt1NCKO mice
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Figure 2.3: Craniofacial abnormalities in Hdac3Wnt1NCKO mice
(A) Gross image of a control (left) and mutant P0 pup. Mutants have severe cranial
hypoplasia, characterized by a shortened snout (bracket) and micrognathia, and are
unable to feed, as indicated by the absence of a milk spot, present in littermate controls
(arrowhead). Mutants also exhibit eyelid dysplasia (arrow). (B) Optical projection
tomography renderings of P0 heads. (Left panels) Viewed en face, an area of
hemorrhage (black arrowhead) and eyelid closure defects (white arrowhead) are visible
in the mutant. (Right panels) Virtual transverse sections cut through the level of the eyes
demonstrate a cleft palate (arrow) in the mutant. (C) H&E stained coronal sections of
E17.5 heads. Cleft palate is indicated by the arrow. S: Nasal septum. T: Tongue. Scale
bars: (A): 500µm. (B): 2mm. (C): 1.4mm.
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Figure 2.4: Deletion of Hdac3 with Pax3Cre recapitulates the craniofacial
abnormalities observed using Wnt1-Cre
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Figure 2.4: Deletion of Hdac3 with Pax3Cre recapitulates the craniofacial
abnormalities observed using Wnt1-Cre
(A) Gross images of E15.5 embryos. Mutant embryos exhibit fully penetrant
microcephaly, with micrognathia and a shortened snout. (B) H&E stained frontal sections
of E14.5 embryos. Neural crest deletion of Hdac3 with Pax3Cre results in cleft palate (*).
Scale bars: (A,B): 800µm.
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Figure 2.5: Hdac3Wnt1NCKO embryos exhibit defects in craniofacial bone formation
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Figure 2.5: Hdac3Wnt1NCKO embryos exhibit defects in craniofacial bone formation
(A) Alcian blue and alizarin red staining of P0 heads. Red staining indicates ossified
bone, blue staining indicates cartilage. (Inset i) Lateral view of the full skeleton. (Inset ii)
Lateral view of the calvaria. (Inset iii) Caudal view of the calvaria. (Inset iv) Rostral view
of the skull base. Mutants demonstrate absence of the tympanic ring (T) (black arrow),
diminished ossification of the frontal bone (F) (black arrowhead), absence of the ossified
secondary palate (SP) (asterisk), and decreased mineralization along the midline of the
interparietal bone (IP) (white arrow). Mutants also exhibit hypoplasia and decreased
ossification of neural crest-derived viscerocranial structures, including the zygomatic
arch (Z) (white arrowhead). Ossification of the mesodermally-derived parietal bone (P)
remains intact. (B) Goldner’s trichrome staining of E17.5 heads. Green staining
represents bone, red staining represents connective tissues. (Inset i) Asterisk indicates
cleft palate in the mutant. (Inset ii) Open bracket indicates an area of brain herniating
through the base of the skull in the mutant. (Inset iii) Decreased ossification of the
calvaria (C) in the mutant, as indicated by a black bar. BO: Basioccipital. BS:
Basisphenoid. EO: Exoccipital. IP: Intraparietal. M. Mandible. N. Nasal. Scale bars: (A):
1mm. (B): 1.4mm.
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Figure 2.6: Hdac3Wnt1NCKO embryos exhibit intact neural crest migration and
differentiation of osteogenic precursors, but increased apoptosis in the
developing calvaria
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Figure 2.6: Hdac3Wnt1NCKO embryos exhibit intact neural crest migration and
differentiation of osteogenic precursors, but increased apoptosis in the
developing calvaria
(A,B) GFP, Runx2, and TUNEL staining of E12.5 heads. (Insets i,ii) Neural crest cells
properly migrate to the outer layers of the developing calvaria and frontal bone
primordium, shown here by fate mapping with the Z/EG reporter. (Inset iii) Mutant
calvaria exhibit a normal pattern of Runx2 staining by immunohistochemistry, suggesting
that differentiation of osteogenic precursors is maintained at this developmental stage.
(Inset iv,C) TUNEL staining of adjacent sections reveals that neural crest cells exhibit
significantly decreased survival in the frontal bone primordium of Hdac3Wnt1NCKO
embryos. (*) denotes p <0.05. Scale bars: (A-C): 200µm.
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Figure 2.7: The loss of Hdac3 causes hypoplasia of neural crest-derived dental
mesenchyme
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Figure 2.7: The loss of Hdac3 causes hypoplasia of neural crest-derived dental
mesenchyme
(A-F) H & E stained frontal sections of control and mutant heads at E17.5. Early stages
of tooth morphogenesis, including epithelial invagination (A,B) and mesenchymal
specification (C,D) occur normally in the absence of Hdac3. (E,F) However, at E17.5, the
dental pulp shows decreased bulk in mutants. Ep: Epithelium. M: mesenchyme. Scale
bar: 200µm.
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Figure 2.8: Cleft palate in Hdac3Wnt1NCKO mice results from increased apoptosis in
the neural crest-derived palatal shelves
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Figure 2.8: Cleft palate in Hdac3Wnt1NCKO mice results from increased apoptosis in
the neural crest-derived palatal shelves
(A-H,A’-H’) H&E stained frontal sections of control and mutant embryos at the level of
the anterior and posterior palatal shelves. (A-D,A’-D’) In control embryos, the palatal
shelves (P) expand towards the mandible (M) before elevating above the tongue (T),
meeting in the midline at E14.5 and ossifying by E17.5. (E-H,E’-H’) In mutant embryos,
the palatal shelves are hypoplastic at E12.5 and do not meet in the midline at E14.5 (*),
although the medial aspects of the palatal shelves do elevate above the tongue
(arrowheads). (I) Images show the areas defined as palatal shelves in control and
mutant embryos at E12.5. Phospho-histone H3 (pH3)- (arrows) and TUNEL(arrowheads) positive nuclei were counted relative to total nuclei in serial sections of the
pharyngeal arch mesenchyme. Asterisk denotes p < 0.05. Scale bars: (A-H,A’-H’):
400µm. (I): 50µm.
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Figure 2.9: Dysregulation of cell cycle genes and the Msx-Bmp4 apoptotic
pathway in Hdac3Wnt1NCKO cranial mesenchyme
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Figure 2.9: Dysregulation of cell cycle genes and the Msx-Bmp4 apoptotic
pathway in Hdac3Wnt1NCKO cranial mesenchyme
(A) Representative fluorescent images showing the area of cranial mesenchyme
microdissected for E12.5 expression profiling. (B-D) Quantitative RT-PCR results. (B)
Expression of Hdac3, but not other class I Hdacs, is decreased in mutant tissue. (C)
Mutant cranial mesenchyme exhibit significant dysregulation of cell cycle regulatory
genes. (D) Among important regulatory genes involved in craniofacial development,
Bmp4, Msx and Tbx expression are significantly altered. (E,F) In situ hybridization of
Msx1and Msx2 in transverse sections of E12.5 heads and TUNEL staining. (E)
Expression of Msx1 transcripts is increased in mutant dental mesenchyme (Insets ii,iv)
compared to littermate control (Insets i,iii). Expression of Msx2 transcripts is increased in
mutant dental mesenchyme (Insets viii,x) compared to littermate control (Insets vii,ix).
TUNEL staining (Insets v,vi,xi,xii) of adjacent sections merged with images of Msx
expression reveals increased apoptosis in mutant versus control embryos in the areas of
higher Msx expression (arrows). (F) Expression of Msx1 transcripts is increased in
mutant palatal shelves (Insets ii,iv) compared to littermate control (Insets i,iii), as well as
apoptosis labeled by TUNEL staining of adjacent sections (Insets v,vi) (arrows). (*)
denotes p <0.05. Scale bars: (A): 150µm. (E,F): 200µm.
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Figure 2.10: Loss of p21 does not rescue craniofacial abnormalities in
Hdac3Wnt1NCKO mutants
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Figure 2.10: Loss of p21 does not rescue craniofacial abnormalities in
Hdac3Wnt1NCKO mutants
H&E stained frontal sections of E16.5 heads. Neural crest deletion of Hdac3 on a p21+/or p21-/- background results in cleft palate (arrow). Scale bar: 400µm.
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Figure 2.11: Core regulators of palatogenesis are not significantly dysregulated in
Hdac3Wnt1NCKO embryos
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Figure 2.11: Core regulators of palatogenesis are not significantly dysregulated in
Hdac3Wnt1NCKO embryos
Quantitative RT-PCR of microdissected E12.5 cranial mesenchyme. Mutant embryos
express similar levels of Osr2 and Shox2 - known regulators of palate development - as
littermate controls.
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Figure 2.12: Knockdown of Msx1 or Msx2 partially rescues proliferation defects of
Hdac3Wnt1NCKO explants
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Figure 2.12: Knockdown of Msx1 or Msx2 partially rescues proliferation defects of
Hdac3Wnt1NCKO explants
(A) siRNA-mediated knockdown of Msx1 and/or Msx2 in microdissected E12.5 cranial
mesenchyme partially restores proliferation of mutant cells to wild-type levels as
measured by phospho-histone H3 immunohistochemistry. (B) Validation of siRNAmediated Msx knockdown. Transfection of cranial mesenchyme with 50nM siRNA
produces partial but significant loss of Msx transcripts as measured by quantitative RTPCR. (*) denotes p <0.05.
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Chapter 3. Genome-Nuclear Lamina interactions regulate cardiac progenitor cell
behavior

Summary

In Chapter 1, I introduced the cardiac progenitor cell populations that give rise to
the cell types found in the heart including cardiomyocytes, smooth muscle and
endothelial cells. Appropriate expansion and differentiation of these progenitor pools is
critical for patterning of the developed heart. Progenitor cells require coordinated
expression of lineage-specific genes to differentiate into one of several daughter cell
lineages. Epigenetic regulators are ideally positioned to synchronize transcriptional
activity of disparate genomic loci through several mechanisms including histone
modifications, nucleosome repositioning and altered higher-order chromatin structure.
Mapping of chromatin dynamics within the nucleus in several systems has revealed that
gene positioning often correlates with changed expression patterns, however the direct
effect of these changes upon cell fate remains unclear. In this chapter, I demonstrate
that Hdac3 functions in a deacetylase-independent manner as a repressor of the
cardiomyocyte lineage. Loss of Hdac3 promotes differentiation into cardiomyocytes by
de-repressing a myocyte gene program. Furthermore, I propose that Hdac3 serves as a
tether between lineage-specific genes and the nuclear lamina, a transcriptionally
silenced subnuclear region. Artificial tethering of Hdac3-bound genes to the nuclear
lamina restores baseline myocyte differentiation, supporting this hypothesis.
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Introduction

As I introduced in Chapter 1, cardiac development requires precise formation and
differentiation of several progenitor populations. Classical lineage tracing studies in chick
and mouse models first identified a region known as the cardiac crescent that
contributes to the primitive heart tube and working myocardium (Cohen-Gould and
Mikawa, 1996; Srivastava, 2006). Progenitors emerging from the cardiac crescent, or the
first heart field, are followed by a second wave of cells that arise posterior to the cardiac
crescent and eventually populate the right ventricle, atria and outflow tract. The
progenitors of this second heart field (SHF) are thought to be multipotent, differentiating
into cardiomyocytes, smooth muscle cells and endothelium (Kattman et al., 2006, 2011;
Moretti et al., 2006; Wu et al., 2006). Specification of these precursor cells to various
cardiovascular cell types requires coordinated regulation of numerous, lineage-specific
genes. Precise control of progenitor cell commitment is essential for appropriate
patterning of the developing embryo, and perturbations of the gene regulatory networks
can lead to congenital defects (Bruneau, 2013; Davidson, 2010; Santen et al., 2012;
Zaidi et al., 2013).

Epigenetic modifiers such as histone deacetylases (HDACs) localize to hundreds
of genomic loci to regulate transcriptional activity, offering a convenient mechanism for
synchronizing expression of broad gene programs. HDACs typically act by removing
acetyl modifications from lysine residues of histone tails to promote a heterochromatic
state and repression of gene transcription (Haberland et al., 2009b). Furthermore,
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several HDACs are known to regulate cardiac morphogenesis and stress responses by
altering expression of diverse sets of genes (Lewandowski et al., 2014; Montgomery et
al., 2007; Sun et al., 2011; Trivedi et al., 2007, 2008, 2010). Hdac3 is unique among the
canonical (class I and II) HDACs for its interaction with co-repressors NCoR and SMRT
and its absolute requirement during early embryogenesis (Bhaskara et al., 2008;
Guenther et al., 2001). While Hdac3 is essential for repression of broad genetic
programs in neural crest, hematopoietic stem cells and hepatocytes, little is known of its
function in cardiac progenitors (Singh et al., 2011b, 2013; Summers et al., 2013; Sun et
al., 2012) although regulation of Tbx5 has been implicated (Lewandowski et al., 2014).

In addition to forming complexes with co-repressors such as NCoR, SMRT and
NuRD, HDACs interact with proteins bound to the inner nuclear membrane including
emerin, Lamin B receptor and Lamina-associated polypeptide 2 (LAP2) (Demmerle et
al., 2013; Guarda et al., 2009; Somech et al., 2005). Accumulation of HDACs and other
transcriptional repressors at the nuclear lamina creates a “silencing environment”
responsible for low expression levels of genomic loci positioned at the nuclear periphery,
whether by natural movement or artificial tethering (Burke and Stewart, 2013; Milon et
al., 2012; Reddy and Singh, 2008; Reddy et al., 2008; Zullo et al., 2012). These laminaassociated domains (LADs) are most commonly heterochromatic and marked by
repressive histone modifications (Towbin et al., 2012). Furthermore, Hdac3 is
responsible for maintaining certain LADs at the nuclear periphery and repressing genes
contained within these regions (Milon et al., 2012; Zullo et al., 2012). Genome-nuclear
lamina interactions are also remarkably dynamic, changing significantly during
progenitor cell differentiation as lineage-specific genes are being selectively silenced or
83

expressed (Kohwi et al., 2013; Peric-Hupkes et al., 2010). However, whether alterations
in LADs can modulate developmental processes, or whether genome interactions with
the nuclear lamina occur only in response to developmental events has been unclear. I
sought to determine if cardiac progenitor commitment may be controlled by “selective
locking” of cell type-specific genetic loci at the nuclear periphery, preventing ectopic
gene expression and inappropriate differentiation.

In this chapter, I examine the role of nuclear organization in early progenitors
during cardiovascular lineage commitment by modulating the epigenetic modifier Hdac3.
Deletion of Hdac3 in cardiac progenitor cells causes excessive differentiation into
cardiomyocytes in both a cell-based model of cardiac development and in mouse
embryos. Surprisingly, Hdac3 deacetylase activity is not required for repression of
myocyte differentiation, suggesting a non-enzymatic role for Hdac3 in gene silencing.
We discovered that loss of Hdac3 releases several myocyte genes from association with
the nuclear lamina concurrent with increased expression. Artificial tethering of Hdac3 to
the nuclear periphery is sufficient to repress cardiomyogenesis. This work demonstrates
that Hdac3 mediates genome-nuclear lamina interactions and subnuclear gene
positioning and that genome tethering to the nuclear lamina is a mechanism for
regulation of progenitor cell commitment.
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Results

Hdac3 represses ES differentiation to cardiomyocytes

Hdac3 functions as a repressor of broad, genetic programs, attenuating
expression of dozens of genes to modulate large-scale effects such as hepatic
lipogenesis (Feng et al., 2011), cardiac response to metabolic stress (Sun et al., 2011),
and neural crest specification (Singh et al., 2011b, 2013). We sought to determine
whether Hdac3 regulates cardiac progenitor cell fate decisions during embryogenesis.
We modeled cardiac development in vitro by differentiating mouse embryonic stem cells
(ESCs) into multipotent Flk1+PDGFRα+ progenitors that can give rise to cardiomyocyte,
endothelial cell and smooth muscle lineages (Kattman et al., 2006, 2011). Upon
generating a mouse ESC line that enables tamoxifen-induced, Cre-mediated Hdac3
deletion (Figure 3.1A), we induced these transgenic cells to differentiate into cardiac cell
types and added tamoxifen to delete Hdac3 when we observed peak expression of
Flk1+PDGFRα+ progenitors at day 5. Next, we allowed the cells to differentiate until we
observed significant numbers of beating cells at day 8. Analysis by flow cytometry
revealed that progenitor populations in which Hdac3 was deleted yielded significantly
more cardiac Troponin T-positive (cTnT+) cardiomyocytes without increasing smooth
muscle or endothelial cell counts (Figure 3.1B). Notably, this increase in cTnT+ cells was
not due to a change in proliferation as measured by phospho-histone H3-positive cells
(Figure 3.2), suggesting that loss of Hdac3 in cardiac progenitors specifically affects
progenitor fate decisions rather than regulating proliferation. We also observed higher
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expression of cardiomyocyte-specific genes, while no significant change in gene
expression of smooth muscle or endothelial cell markers was observed (Figure 3.1C).
The addition of tamoxifen just 48 hours later when Flk1+PDGFRα cells were no longer
detected, did not yield any significant increases in cardiomyocyte, smooth muscle or
endothelial cell numbers as compared to controls (Figure 3.1D-E). These data suggest
that Hdac3 acts to regulate differentiation during a narrow temporal window at the time
when multipotent cardiac progenitors are present. Additionally, lentiviral overexpression
of Hdac3 during this same time window of differentiation further represses
cardiomyocyte numbers relative to baseline (Figure 3.1F-H). These experiments in
embryonic stem cells suggest that Hdac3 functions to repress progenitor cell
differentiation towards the myocyte lineage.

Hdac3 represses differentiation of FHF and SHF cardiac progenitors

We hypothesized that Hdac3 plays a similar repressive role in cardiac progenitor
cells present in the developing embryo. Using a floxed Hdac3 allele (Hdac3f), we deleted
Hdac3 in vivo in SHF progenitors marked by LIM-homeobox transcription factor Isl1
expression (Mullican et al., 2011; Srinivas et al., 2001). We observed that loss of Hdac3
in SHF cardiac progenitors resulted in embryonic lethality and ventricular hypoplasia
(Figure 3.3A). Furthermore, Hdac3-null hearts were comprised of greater numbers of
myocytes than littermate controls (Figure 3.3B), mirroring the enhanced myocyte
differentiation phenotype observed in the mouse ESC culture system. Next, we
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expanded the cell populations of Hdac3 deletion using a more broadly-expressed Cre to
include both first heart field (FHF) and SHF progenitors (Moses et al., 2001). Loss of
Hdac3 in cells expressing the cardiac homeobox gene Nkx2.5 also yielded hypoplastic
morphology and increased differentiation into cardiomyocytes (Figure 3.3C,D). By
contrast, deleting Hdac3 in committed cardiomyocytes as opposed to undifferentiated
cardiac progenitor cells did not result in embryonic lethality or morphologic changes
during embryogenesis (Figure 3.4) (Montgomery et al., 2008). These results
complement our in vitro studies, establishing that Hdac3 acts during a narrow temporal
window in FHF and SHF progenitors to repress differentiation to the myocyte lineage.

Hdac3 represses a myocyte gene program

Given the canonical function of Hdac3 as a transcriptional repressor, we
hypothesized that Hdac3 suppresses cardiac progenitor specification to the
cardiomyocyte lineage through silencing of a myocyte gene program. Hdac3 deletion in
differentiating mouse ESCs de-represses cardiomyocyte genes such as Myh6, Tnnt2,
Actc1, but not smooth muscle or endothelial cell-specific genes (Figure 3.1C). In vivo,
microarray analysis of Hdac3-null hearts deleted by Nkx2.5Cre revealed an upregulation
of myocyte-specific genes. Classification of upregulated genes by DAVID analysis
revealed that the top category is regulators of muscle contraction. Finally, we validated
several of these myocyte gene changes by qPCR and confirmed increased expression
in Hdac3-null hearts (Figure 3.3E). These results are consistent with Hdac3 functioning
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as a repressor of a myocyte gene program, with loss of Hdac3 de-repressing these
genes and driving precocious differentiation into cardiomyocytes.

Hdac3 represses cardiac differentiation independent of catalytic function

Recent studies suggest that Hdac3 maintains its function as a transcriptional
repressor even without deacetylase activity (Sun et al., 2013; You et al., 2013). To
establish whether Hdac3 catalytic activity is required for regulation of cardiac progenitor
differentiation, we returned to the mouse ESC system (Figure 3.5A). Consistent with our
earlier experiments, deleting Hdac3 with addition of tamoxifen substantially enhanced
differentiation into cardiomyocytes. As expected, exogenous expression of wild-type
Hdac3 partially restored wild-type levels of differentiation (Figure 3.5B). To our surprise,
exogenous expression of an Hdac3 mutant harboring a single Y298H substitution in the
catalytic pocket that abolishes deacetylase activity of the enzyme while maintaining
interactions with known binding partners (Lahm et al., 2007; Sun et al., 2013) rescued
differentiation equally as well as wild-type Hdac3 (Figure 3.5B). This unexpected
observation suggests that Hdac3 represses cardiomyocyte differentiation independent of
its histone deacetylase activity.

We sought to determine whether Hdac3 catalytic activity is required for normal
cardiac development in vivo. Mice harboring mutations in the Deacetylase Activating
Domains of both NCoR and SMRT (NS-mDAD) lack detectable Hdac3 enzymatic activity
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in vivo (You et al., 2013). Further analysis of these mice revealed that despite no
detectable Hdac3 deacetylase activity, they are able to maintain normal cardiac
development and morphology through birth (Figure 3.5C) in contrast to embryos lacking
Hdac3 protein in cardiac progenitors (Figure 3.3). NS-mDAD mice survive to term and
do not exhibit ventricular hypoplasia. Furthermore, expression analysis revealed that
these mice express critical myocyte genes at levels similar to wild-type controls (Figure
3.5D). Taken together, our in vitro and in vivo studies suggest that Hdac3 exhibits a
deacetylase-independent function to regulate cardiac development and progenitor
differentiation.

Hdac3 functions with Lamina Associated Domains to repress myocyte genes

Hdac3 has been proposed to function as a component of a protein complex
responsible for the structural maintenance of nuclear Lamina Associated Domains
(LADs). Previous studies suggest that Hdac3 interacts with a zinc finger transcription
factor cKrox (ThPOK) and nuclear membrane protein Lap2β to mediate tethering of
condensed (repressed) regions of chromatin to the inner nuclear membrane (Melnick et
al., 2002; Somech et al., 2005; Zullo et al., 2012). We hypothesized that Hdac3 acts in
this complex to prevent excess cardiac progenitor differentiation by repressing critical
myocyte genes via tethering to the nuclear membrane. Consistent with this model,
knockdown of cKrox, a DNA-binding member of this LAD complex, phenocopies the
significant increase in ESC to cardiomyocyte differentiation that we observe with Hdac3
depletion (Figure 3.6A,B).
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Furthermore, expression analysis and chromatin immunoprecipitation reveals
that several myocyte-specific genes which are repressed by Hdac3 are bound by Lamin
B1. Lamin B1 is a core component of the nuclear lamina and DNA bound by Lamin B1
is by definition within a LAD. Deletion of Hdac3 in differentiating mouse ESCs releases
myocyte genes including those encoding structural components (Ttn, Trdn) and ion
channels (Kcnh7, Kcnc2, Kcnq1) from the nuclear periphery, as determined by loss of
binding to Lamin B1 (Figure 3.6C). This loss of LaminB1 occupancy is accompanied by
higher expression of these same genes (Figure 3.6D). These results lead us to propose
that Hdac3 acts in cardiac progenitor cells to silence a lineage-specific gene program by
retaining key genomic loci at the nuclear periphery.

Landscape of LADs during cardiac development

Previous studies of three-dimensional chromatin organization within the nucleus
have focused on in vitro model systems, and little is known about the dynamics of
lamina-chromatin interactions during normal embryonic development (Peric-Hupkes et
al., 2010; Sadaie et al., 2013; Shah et al., 2013). To provide a global view of nuclear
architecture during cardiac development, we mapped DNA-lamina interactions genomewide at multiple embryonic timepoints by Lamin B1 chromatin immunoprecipitation
followed by sequencing (ChIP-seq). We identified about 1500 lamina-bound regions in
e9.5 and e12.5 hearts (Figure 3.7), comparable with numbers of LADs seen in other
systems (Peric-Hupkes et al., 2010; Shah et al., 2013).
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Forcible tethering of Hdac3-bound genes to the nuclear periphery represses
differentiation

To specifically test whether Hdac3 represses progenitor differentiation by
tethering myocyte genes to the nuclear lamina, we designed a system in which Hdac3 is
obligated to function as a LAD tether. We generated a construct fusing Flag-tagged
Hdac3 to nuclear membrane protein Lap2β (Hdac3-Lap2β). Lap2β exclusively localizes
to the inner nuclear membrane, and immunocytochemistry confirms the Hdac3-Lap2β
fusion also localizes to the nuclear membrane (Figure 3.8A,B). Returning to our mESC
system, we deleted endogenous Hdac3 with addition of tamoxifen and exogenously
expressed the Hdac3-Lap2β fusion, enabling us to restrict Hdac3 to the nuclear
periphery to interrogate function at this specific subnuclear compartment. Transduction
of the Hdac3-Lap2β fusion restores differentiation to equivalent levels as transducing
wild-type Hdac3, a result not seen with an eGFP-Lap2β control (Figure 3.8C).
Furthermore, expression of the deacetylase-deficient Y298H Hdac3 mutant fused to
Lap2B also restors differentiation equivalent to wild-type Hdac3. These data suggest that
tethering Hdac3-bound loci to the nuclear membrane does not require deacetylase
activity and is sufficient to repress cardiac differentiation into cardiomyocytes.
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Discussion

Progenitor cells require coordinated expression of complex gene patterns to
promote differentiation to specific lineages while repressing alternative cell fates
(Pongubala et al., 2008). Higher-order chromatin organization within the
subcompartments of the nucleus significantly alters activity of large genomic domains,
making it possible to regulate whole gene programs simultaneously. The region
surrounding the nuclear lamina is enriched for transcriptionally silent genes decorated by
repressive histone modifications. Recent work suggests that genome-nuclear lamina
interactions are dynamic, rearranging during progenitor cell commitment and
differentiation (Kohwi et al., 2013; Peric-Hupkes et al., 2010). However, to date the
functional significance of these rearrangements has remained unclear.

The results presented in this chapter demonstrate that LAD positioning is
maintained by the epigenetic modifier Hdac3, and altered nuclear localization of lineagespecific genes is accompanied by precocious cardiac progenitor differentiation. Loss of
Hdac3 promotes upregulation of a myocyte gene program and excessive formation of
cardiomyocytes both in vivo and in an ES cell-based system. A number of these
myocyte-specific genes alter their interaction with the nuclear lamina during normal
development and are repositioned away from the nuclear periphery upon Hdac3
deletion. Artificial tethering of Hdac3-bound genes to the nuclear membrane partially
restores baseline myogenesis. This work represents, to our knowledge, the first analysis

92

of a cardiac defect influenced by disruption of nuclear lamina-mediated gene program
silencing.

Human diseases involving defects in the nuclear lamina, collectively known as
laminopathies, manifest with developmental defects including muscular dystrophies,
cardiomyopathies and premature aging. Hutchinson-Gilford progeria syndrome (HGPS)
results from mutations in Lamin A and leads to deregulation of chromatin structure and
increased DNA damage (Van Bortle and Corces, 2013; Kubben et al., 2012). Mutations
in Lamin A or its interacting protein Emerin also cause Emery-Dreifuss muscular
dystrophy (EDMD), a degenerative muscular disease that is nearly always associated
with cardiac abnormalities. A C. elegans model of EDMD exhibits abnormal positioning
of heterochromatin and a muscle-specific transgene (Mattout et al., 2011). These
conditions are caused by disruption of the nuclear lamina, however further study is
required to determine whether rearrangement of genome-nuclear lamina interactions
explains some or all of the observed phenotypes.

I propose a model by which a lineage-specific gene program is repressed in
progenitor cells by localizing to the “silenced environment” of the inner nuclear lamina
(Figure 3.9). As I discuss in Chapter 4, it is unlikely that progenitor cell behavior is
exclusively regulated by genome-nuclear lamina interactions, however higher-order
chromatin organization remains a powerful mechanism for coordinated gene expression.
Nuclear localization studies by FISH reveal differential clustering of active versus
repressed gene loci (Shopland et al., 2006). Several epigenetic regulator complexes
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including NuRD and Brahma are found at the nuclear periphery, suggesting that several
components are in place for repression of tethered gene loci (Euskirchen et al., 2011;
Milon et al., 2012). Furthermore, another component of the subnuclear structure, the
nuclear matrix, plays an important role in transcriptional activation of developmentally
required homeodomain protein targets (Skowronska-Krawczyk et al., 2014). Collectively
with the work presented in this chapter, there is growing evidence that the distribution of
the three dimensional chromatin organization within the nucleus can have powerful
effects on gene expression networks and developmental dynamics.
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Materials and methods

Mice

Isl1Cre, Nkx2.5Cre, aMHC-Cre, Hdac3flox, and CMV-creERT mice were maintained
on mixed CD1/B6/129 genetic backgrounds separated by 4-8 generations of
interbreeding from pure parental strains (Agah et al., 1997; Hayashi et al., 2002; Moses
et al., 2001; Mullican et al., 2011; Srinivas et al., 2001). NS-mDAD mice were
maintained on a C57BL/6 background (You et al., 2013). Mice were genotyped using
previously described Cre-specific PCR primers (5’-TGC CAC GAC CAA GTG ACA GC3’, 5’-CCA GGT TAC GGA TAT AGT TCA TG-3’) (Heidt and Black, 2005), and primers
designed to distinguish between the control and floxed Hdac3 allele (5’-GCA GTG GTG
GTG AAT GGC TT-3’, 5’-CCT GTG TAA CGG GAG CAG AAC TC-3’). Littermate
embryos were analyzed in all experiments unless otherwise noted. The University of
Pennsylvania Institutional Animal Care and Use Committee approved all animal
protocols.

ES cell derivation and differentiation

Embryonic stem cells were derived from CMV-creERT; Hdac3f/f mice as
previously described (Nagy et al., 2002). Briefly, blastocysts were collected at e3.5 and
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cultured on STO feeder cells in standard ESC media +LIF + 50µM MEK1 inhibitor (Cell
Signaling #9900) for 7 days until blastocyst hatches and forms colony. Individual
colonies were subcultured for about 1 week when MEK inhibitor is removed and cells
passaged as a normal ESC line.

Cardiac differentiation was adapted from published protocols (Christoforou et al.,
2008; Kattman et al., 2011). Briefly, ESCs were cultured and maintained on a feeder
layer of mitotically inactivated MEFs in DMEM with 15% FBS (Fisher Scientific #
SH3007003) and ESGRO leukemia inhibitory factor. Differentiation through hanging
droplets method was initiated following ESC dissociation and suspension at 5 x 104
cells/ml in DMEM with 10% FBS (Atlanta Biologicals #S11550) without LIF in 20µl drops.
Two days after droplets formation, embryoid bodies (EBs) were transferred in
suspension on poly-HEMA coated dishes. After another two days, EBs were plated on
gelatin coated dishes in cardiac differentiation media (StemPro-34 SF medium
[Invitrogen #10639-011] supplemented with 5ng/ml VEGF [R&D systems], 10ng/ml
bFGF [R&D systems], 12.5ng/ml FGF10 [R&D systems], 2.5µM XAV939 [Cayman
Chemical #13596], 1mM Ascorbic Acid [Sigma] and 2mM Glutamax [Invitrogen]).
Beating cells were visible within 48 hours.

4-Hydroxytamoxifen (Sigma #T176) was dissolved in ethanol and added at
1µg/ml final concentration to delete Hdac3.
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Flow cytometry

ES-derived cells and embryonic hearts were fixed, permeabilized and stained for
flow cytometry according to standard protocols. Briefly, cells were dissociated in 1mg/ml
collagenase solution, fixed in Fixation buffer (eBioscience #00-8222-49), permeabilized
in 1x Permeabilization buffer (eBioscience #00-8333-56) and stored in 1% BSA.
Embryonic hearts were dissociated in 5mg/ml collagenase at 37oC for 10 minutes with
occasional trituration before fixation and permeabilization steps. Cells were stained with
primary and secondary antibodies for 1 hour each in Permeabilization buffer,
resuspended in Flow Cytometry buffer (eBioscience #00-4222-26) and analyzed on BD
FACSAria II cytometer. Antibodies used were cardiac Troponin T (1:100, Thermo #MS295-P), Smooth Muscle Actin (1:100, abcam #ab5694), CD31 (1:100, abcam #ab28364),
Phospho-Histone H3 (1:50, Cell Signaling #9701), anti-mouse AlexaFluor 488 (1:200,
Invitrogen #A21200) and anti-rabbit AlexaFluor 647 (1:200, Invitrogen #A21244)

RNA isolation,

complementary DNA synthesis,

quantitative

RT-PCR

and

Microarray

ES-derived cells or microdissected embryonic hearts were isolated in Trizol
(Invitrogen # 15596-026) and RNA was obtained using the Qiagen RNeasy spin column,
with on-column DNAse I digestion. Complementary DNA (cDNA) was synthesized
according to kit instructions with the Superscript III system (Invitrogen). Quantitative RT97

PCR was performed in triplicate using Sybr Green (Applied Biosystems). Gapdh was
used as a reference control gene. Quantitative RT-PCR primers (Table 3.2) were
designed using IDT software. Microarray analysis was performed by the University of
Pennsylvania Next Generation Sequencing Core using 2-color hybridization technique
with a whole genome mouse Agilent array. Four pools each of mutant Nkx2.5Cre; Hdac3f/f
and littermate control RNA were hybridized to the array. Each pool contained three
hearts microdissected from e9.5 embryos.

Western blot analysis

Lysates were run on 4-12% Bis-Tris protein gels (Invitrogen #NP0335) and blots
were probed with anti-Hdac3 (1µg/ml, abcam #ab7030) or anti-β-actin (1:1000, Cell
Signaling #4967) according to the instructions of the manufacturer and as previously
described (Aghajanian et al., 2014). Visualization was achieved using ECLPrime (GE
Life Sciences #RPN2232).

Histology

Histological analysis was performed on paraformaldehyde-fixed, paraffin
embedded slides as previously described (High et al., 2008). Embryos were dissected in
cold PBS, fixed overnight in 2% paraformaldehyde, dehydrated into 100% ethanol,
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embedded in paraffin and sectioned. H&E staining was performed using standard
procedures. All control and mutant histological images shown for comparison were taken
at the same exposure and contrast settings, using NIS Elements software.

Plasmids, transfection and transduction

Expression plasmids for Flag-Hdac3 and Flag-Hdac3 Y298H were generously
provided by P. Gallinari (Lahm et al., 2007). Wild-type and mutant Hdac3 were cloned
into AgeI-BsrGI sites of lentivirus FUGW (Addgene plasmid 14883, deposited by David
Baltimore, (Lois et al., 2002)) for transduction of ESC-derived cells. Lap2β was PCR
amplified from pEGFP-Lap2β (generously provided by J. Ellenberg (Beaudouin et al.,
2002)) and cloned into BsrGI site of FU-Hdac3 or FU-Hdac3 Y298H, creating a fusion
protein with Hdac3 or Hdac3 Y298H. cKrox shRNA was generously provided by K.
Reddy (Sigma clone TRCN0000194510). Lentiviruses were generated in Lenti-X 293T
cells (Clontech # 632180) according to manufacturer instructions. Plasmid transfections
were performed with Fugene 6 (Promega #E2691) according to manufacturer
instructions.

Lamin B1 ChIP-qPCR and ChIP-seq

Lamin B1 ChIP was performed from ES-derived cells or microdissected
embryonic hearts as previously described (Shah et al., 2013). hiSeq-50SR sequencing
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was performed by the University of Pennsylvania Funcitonal Genomics Core. qPCR
primers to validate ChIP targets in ES-derived cells were designed using IDT software.
Primers used are listed in Table 3.3.

For assigning lamina-associated domains from sequencing data, the following
method was used: We partitioned the genome into windows of length 1000 bp. Each
window w has aw input reads and bw ChIP reads. We collected reads from several ChIP
and input sets, and we processed only windows that have at least one read mapped in
one of the sets. Other windows are ignored, we call them “null windows”. As a result, we
do consider windows with aw = bw = 0 if they have reads in some other data sets. The
“significance” of an interval of windows is related to the p-value that we observe for a
particular number of signal reads in that interval, but we normalize that number in each
window. In the null model the windows are permuted, so the content of each window is
an independent event, and the probability of seeing some combination of independent
events is the product but we add scores, not multiply. Therefore we use the score that is
related to the LOGARITHM of the probability, thus the sum of scores for a block of
windows is related to the logarithm of the product, so it is related to the probability for the
block.

We consider the windows with a particular number of input reads:
ni is the number of all windows with aw = i (i input reads)
sik is the number of all windows with aw = i and bw = k
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mi is the median for i, a number m such that
si0 + … + si(m-1) and si(m+1) + … + simaximum are both smaller than ni / 2

Score(i,mi) = 0, zero significance for the median
For k < mi we define tik = si0 + … + sik and Score(i,k) = log (2tik / ni)
For k > mi we define uik = sik + … + simaximum and Score(i,k) = -log (2uik / ni)

With this formula, if the count of signal reads is the median (among windows with
the same number of reads), then it gets score 0, below, negative, above, positive.

The idea of the scoring is that we prefer to select windows with positive scores
and avoid selecting windows with negative scores. However, with the described method
of assigning scores, about half of the windows have positive score and about half,
negative, while the target region occupy less than half of the genome. Therefore we use
Score(w) = Score(aw, bw) – α where α is the score adjustment, the same for all non-null
windows. The larger score adjustment we use, the fewer windows belong to the selected
regions. The score adjustment is one of the two parameters supplied by the user.

We create blocks of consecutive windows, so either all windows in a block
belong to one of the selected regions, or none of them does. We start with maximum
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blocks such that all windows in a block are negative (scores below zero) or all are
positives (scores at least 0). In this way, blocks of windows from a particular
chromosome form a list, sorted by the position, and positive and negative blocks
alternate.

In the case of the mouse genome, we start with roughly 2.5E+06 windows and
1E+06 initial blocks. Then we performed the steps described below until there are
exactly N positive blocks, and we return the positive blocks as the selected regions. N is
the second parameter supplied by the user.

To perform a step of the algorithm, we consider a block with the minimum
ABSOLUTE value of the sum of scores of its windows. If it is the first or the last block in
a chromosome list, we remove it, otherwise we merge it with the two neighbor blocks.

Immunocytochemistry

Transfected 293T cells grown on glass coverslips, fixed in 4% paraformaldehyde
for 10 minutes, permeabilized in 0.25% TritonX-100 +3% BSA for 15 minutes, blocked in
3% BSA and incubated in primary and secondary antibodies for 1 hour each. After
washes, slides were mounted in DAPI-containing mounting solution (Invitrogen #P36931) and imaged. All images shown for comparison were taken at the same exposure
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and contrast settings, using NIS Elements software. Antibodies used were anti-GFP
(1:100, Cell Signaling #2956), anti-Flag (1:1000, Sigma #F1804), anti-mouse AlexaFluor
488 (1:400, Invitrogen #A21200) and anti-rabbit AlexaFluor 568 (1:400, Invitrogen
#A11011).
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Table 3.1: SHF-specific Hdac3 deletion results in embryonic lethality
Isl1Cre; Hdac3f/+ x Hdac3f/+
P0

No. Observed

Observed

No. Expected

Expected

Hdac3

12

0.12

12.3

0.13

Hdac3f/+

31

0.32

24.5

0.25

Hdac3f/f

17

0.17

12.3

0.13

Isl1Cre; Hdac3+/+

16

0.16

12.3

0.13

Isl1Cre; Hdac3f/+

22

0.22

24.5

0.25

Isl1Cre; Hdac3f/f

0

0

12.3

0.13

Total

98

+/+

χ2

0.004
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Table 3.2: qRT-PCR Primers for expression analysis
Gene name
Gapdh

Protein name
Gapdh

Sequence (5’ – 3’)
CGTCCCGTAGACAAAATGGT
GAATTTGCCGTGAGTGGAGT

Hdac3

Hdac3

CCATTCTGAGGACTACATCGAC
TGTGTAACGGGAGCAGAAC

Tnnt2

cTroponinT

ATCGAGGCTCACTTCGAGAAC
GTCTTTGAGGGAAATCAGCTCC

Myh6

alpha-MHC

ACGGTGACCATAAAGGAGGA
TGTCCTCGATCTTGTCGAAC

Actc1

Cardiac Actinin

GACCTCACTGACTACCTCATG
TCTCGTTCTCAAAATCCAGGG

Ttn

Titin

GACACCACAAGGTGCAAAGTC
CCCACTGTTCTTGACCGTATCT

Nkx2.5

Nkx2.5

GACAGGTACCGCTGTTGCTT
AGCCTACGGTGACCCTGAC

Cnn1

Calponin

CTTCTGCACATTTTAACCGAGG
AATGATCCCGTCTTTGAGGC
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Pecam1

PECAM1

ACATTCACAGATAAGCCCACC
TCTTTCACAGAGCACCGAAG

Calca

Calcitonin

CTCCAGGCAGTGCCTTTGAG
GGCGAACTTCTTCTTCACTGAGA

Kcnq1

Kcnq1

ACCGTCTTCCTCATTGTTCTGG
GACAATCTCCATCCAGAAGAGG

Kcnc2

Kcnc2

TCCAGTACGAAATCGAAACGG
GGGTGAGAAAACAATTCGGACTA

Kcnh7

Kcnh7

CCAGGAAACTGGACCGATACT
CCAATCGCATACCAGATGCAA
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Table 3.3: qPCR primers for ChIP analysis
Gene name
Actc1

Protein name
Cardiac Actinin

Sequence (5’ – 3’)
GCTCAGTCTCATCCTCTACT
TCAGTCTCACCTCCTGATAC

Ttn

Titin

CTCTATCTGGTGTTTCCTTTC
AAAGGCAGAAGGGTCTAA

Calca

Calcitonin

CATGTGTAAGGAGCAGAGTAAG
AGTTCCATGCCCACTATCT

Kcnq1

Kcnq1

CATCTAAGGTCCCTCACTTTG
CAGGCATCCTCAGGAAATAG

Kcnc2

Kcnc2

CTGGCTCAGACCCATAAA
AATGGAGGACACCAGAAG

Kcnh7

Kcnh7

TCTGTTCCTCTCTGTCATT
GTCTGGGATTGGCTTATTT

Ctnnd

Catenin, Delta

GAGTAGAAAGGAGGGAGTAG
TCTCTGACCTGTGATCTTT

107

Figure 3.1: Hdac3 represses ES differentiation to cardiomyocytes
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Figure 3.1: Hdac3 represses ES differentiation to cardiomyocytes
(A)Schematic of Hdac3 deletion in differentiating mouse ESCs of genotype CMVcreERT; Hdac3f/f. Deletion is induced with tamoxifen at day 5 when cardiac progenitors
are present. (B) Analysis by flow cytometry of cardiac TroponinT (cTnT)+, Smooth
Muscle Actin(SMA)+, and PECAM1+ cells on day 8 of differentiation. Y-axis of % cardiac
cells represents percent of total cTnT+, SMA+ and PECAM1+ cells. (C) Gene expression
analysis by qRT-PCR on day 8 of differentiation after tamoxifen addition at day 5. (D)
Schematic ofHdac3 deletion with tamoxifen addition at day 7 of differentiation, two days
after peak expression of Flk1+,PDGFRα+ progenitors. (E) Flow cytometry of cTnT+, SMA+
and PECAM1+ cells after Hdac3 deletion at day 7 of differentiation. (F) Schematic of
Hdac3 deletion and overexpression at day 5 of differentiation. (G) Flow cytometry
analysis demonstrates fewer cTnT+ cells after Hdac3 overexpression and more cTnT+
cells after Hdac3 deletion. (H) Western blot analysis to confirm Hdac3 overexpression
and deletion. * denotes p<0.05. ns denotes p>0.05.
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Figure 3.2: No change in proliferation upon Hdac3 deletion
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Figure 3.2: No change in proliferation upon Hdac3 deletion
Flow cytometry analysis of phospho-histone H3+ cells in differentiating ESCs at days 5,
6 and 8 of differentiation after vehicle or tamoxifen addition at day 5.
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Figure 3.3: Hdac3 inhibits differentiation of FHF and SHF cardiac progenitors in
vivo by repressing a myocyte gene program
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Figure 3.3: Hdac3 inhibits differentiation of FHF and SHF cardiac progenitors in
vivo by repressing a myocyte gene program
(A)Deletion of Hdac3 in Isl1-expressing SHF progenitors results in ventricular
hypoplasia, thin myocardium and embryonic lethality. H&E staining at e10.5 reveals
morphology and boxed area highlights thinned right ventricle wall in mutants relative to
controls. Scale bars 50µm. (B) Flow cytometry analysis of cTnT+, SMA+ and PECAM1+
cells from dissociated e10.5 Isl1Cre control and Hdac3-null hearts. (C) Deletion of Hdac3
in Nkx2.5-expressing FHF and SHF progenitors at e16.5. Box highlights area of right
ventricle with thin myocardium. Scale bars 200µm. (D) Flow cytometry analysis of
dissociated e16.5 Nkx2.5Cre control and Hdac3-null hearts. (E) Gene expression analysis
by qRT-PCR of e9.5 Nkx2.5Cre control and Hdac3-null hearts. * denotes p<0.05. ns
denotes p>0.05.
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Figure 3.4: Hdac3 deletion in cardiomyocytes does not disrupt cardiac
morphology
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Figure 3.4: Hdac3 deletion in cardiomyocytes does not disrupt cardiac
morphology
Histological analysis of cardiomyocyte-specific deletion of Hdac3 at P0 by H&E staining.
Box highlights normal right ventricle myocardium in both control and Hdac3-null hearts.
Scale bars 100µm.
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Figure 3.5: Hdac3 represses cardiac differentiation independent of catalytic
function
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Figure 3.5: Hdac3 represses cardiac differentiation independent of catalytic
function
(A)Schematic of Hdac3 deletion and transduction of wild-type or Y298H mutant Hdac3 in
differentiating ESCs. (B) Analysis of cTnT+ cells by flow cytometry of ESCs on day 8 of
differentiation after addition of vehicle or tamoxifen at day 5 with simultaneous
transduction of GFP control or wild-type Hdac3 or Y298H mutant Hdac3. (C) H&E
staining of NS-mDAD mice at P0. Scale bars 200µm. (D) Gene expression analysis of
myocyte genes by qRT-PCR from P0 NS-mDAD hearts. * denotes p<0.05. ns denotes
p>0.05.
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Figure 3.6: Hdac3 functions with Lamina Associated Domains to repress myocyte
genes
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Figure 3.6: Hdac3 functions with Lamina Associated Domains to repress myocyte
genes
(A)Schematic of Hdac3 deletion or cKrox knockdown at day 5 of ESC differentiation. (B)
Analysis by flow cytometry of cTnT+ cells with control shRNA or cKrox shRNA or
tamoxifen addition. (C) LaminB1 ChIP-qPCR at myocyte genes was performed with
ESCs at day 8 of differentiation after addition of vehicle or tamoxifen at day 5. (D) Gene
expression analysis of myocyte genes in differentiation day 8 ESCs indicates myocyte
genes in LADs are upregulated upon Hdac3 deletion. * denotes p<0.05. ns denotes
p>0.05.
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Figure 3.7: Dynamic landscape of LADs during cardiac development

120

Figure 3.7: Landscape of LADs during cardiac development
LaminB1 ChIP-seq track from wild-type e9.5 and e12.5 hearts maps LADs genome-wide
during cardiac development. Blue represents Lamin B1 occupancy at e9.5, pink
represents occupancy at e12.5. Black bar annotates individual LADs. Scale bar: 200,000
bp
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Figure 3.8: Forcible tethering of Hdac3-bound genes to the nuclear periphery
represses differentiation
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Figure 3.8: Forcible tethering of Hdac3-bound genes to the nuclear periphery
represses differentiation
(A)Schematic of Hdac3-Lap2β fusion expressed in differentiating ESCs at day 5. (B)
Immunofluorescence of 293T cells transfected with EGFP-Lap2β, Hdac3-Lap2β or wildtype Hdac3 and stained for FLAG or GFP with DAPI as a nuclear stain. Scale bars
10µm. (C) Analysis by flow cytometry of cTnT+ cells at day 8 of differentiation after
vehicle or tamoxifen treatment and transduction with GFP, wild-type Hdac3 (WT-Hdac3),
wild-type Hdac3-Lap2β fusion (WT-H3-L2) or Y298H Hdac3 mutant-Lap2β fusion
(Y298H-H3-L2). * denotes p<0.05. ns denotes p>0.05.
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Figure 3.9: Model of LAD-mediated repression of myocyte gene program in
cardiac progenitor cells
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Figure 3.9: Model of LAD-mediated repression of myocyte gene program in
cardiac progenitor cells
Schematic of cardiac progenitor differentiation into cardiomyocyte, smooth muscle and
endothelial cell lineages. Within cardiac progenitor cells (marked by Nkx2.5 and Isl1
expression), Hdac3 interacts with Lap2β and cKrox to tether a myocyte gene program to
the nuclear lamina, repressing transcriptional activity and myocyte commitment.
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Chapter 4. Conclusions and Future Directions

Summary

Progenitor cells are developmental precursors with the capacity to differentiate
into multiple cell types but with a limited ability to self-renew. Appropriate differentiation
of progenitor cells requires coordinated expression of lineage-specific gene programs.
Epigenetics is the study of heritable changes in gene expression not caused by
differences in the DNA sequence. These changes can be widespread across large
genomic regions, offering a convenient mechanism for synchronizing expression of
numerous genes in a progenitor cell. In this dissertation, I studied the role of histone
deacetylase 3, an epigenetic regulator, in the context of neural crest and cardiac
progenitor cell expansion and commitment. Previous studies had identified the
importance of Hdac3 in the development of these and other tissues, however the precise
mechanism by which Hdac3 regulates progenitor cell behavior remained uncertain.

In Chapter 2, I demonstrate that Hdac3 functions in the neural crest as a repressor of
cell proliferation and survival by regulating expression of a core network of factors
required during craniofacial development. These well-studied pathways include the BmpMsx axis, with increased expression of Msx1 and Msx2 sufficient to reduce proliferation
in Hdac3 mutants. These changes in proliferation and survival of neural crest-derived
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mesenchyme cause cleft palate, microcephaly, tooth hypoplasia and other craniofacial
defects.

In Chapter 3, I examine the role of Hdac3 in cardiac progenitor cells of the first and
second heart fields. These cells differentiate into cardiomyocyte, smooth muscle and
endothelial cell lineages and go on to populate the heart. Similar to previous work,
Hdac3 functions as a repressor to inhibit expression of a lineage-specific gene program.
Silencing of cardiomyocyte genes prevents precocious differentiation of cardiac
progenitor cells. Surprisingly, Hdac3 represses the myocyte fate independent of its
deacetylase activity. Instead, Hdac3 functions at the nuclear membrane to tether
myocyte genes to the nuclear lamina, preventing expression of this gene program and
repressing differentiation down the cardiomyocyte lineage. Loss of Hdac3 allows these
cardiac progenitor cells to precociously differentiate into cardiomyocytes, resulting in
ventricular hypoplasia and embryonic lethality.

These results implicate a role for subnuclear organization of chromatin as a regulator
of progenitor cell behavior and lineage commitment during development. This is a novel
direction for the nuclear architecture field and one that offers insight into how cells may
coordinate the factors necessary to drive broad, dramatic changes like adopting new
fates.

127

Future directions

How widespread is nuclear architecture regulation in development?

Previous work on nuclear architecture and lamina associated domains has
primarily focused on in vitro model systems and transgenic cell lines. This includes
mapping chromatin organization in cultured Drosophila cells and cell-based experiments
artificially tethering reporter genes to the nuclear membrane (van Bemmel et al., 2013;
Pickersgill et al., 2006; Reddy et al., 2008). The in vitro work with the closest
developmental corollary is a pioneering study from the van Steensel group mapping
genome-lamina interactions in mouse ESCs differentiating into neurons (Peric-Hupkes et
al., 2010). At four stages of differentiation, the authors performed DamID to mark
chromatin in contact with the nuclear lamina, profiling the dynamic changes in nuclear
organization during differentiation. From this study, a few observations stand out. First,
some LADs are remarkably dynamic, with the level of interaction with the lamina
changing significantly at each time point. Second, during differentiation to the neuronal
lineage, non-neuronal factors are being silenced and repressed at the nuclear periphery.
Third, certain LADs did not change over the course of differentiation, but rather stayed
constitutively bound at the periphery during neuronal specification. Together, these
results suggest that a select portion of the genome dynamically alters subnuclear
localization during progenitor cell commitment.
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The primary study of nuclear architecture-mediated silencing in vivo focuses on
localization of a single gene in Drosophila neural progenitor cells (Kohwi et al., 2013).
The authors identified and visualized hunchback, a transcription factor responsible for
promoting progenitor cell competence and inhibiting differentiation. Fluorescent in situ
hybridization enabled tracking of this gene to the nuclear periphery as neuroblast
progenitors begin to lose competence. Artificial loss of genome-lamina interaction
permitted sustained expression of hunchback and prolonging of progenitor competence.
This study in an invertebrate system suggests that nuclear organization and laminamediated gene regulation influences progenitor cell behavior.

In addition to the mapping study during ESC differentiation, additional work from
the van Steensel group and others has profiled genome-lamina interactions in multiple
cell types (van Bemmel et al., 2013; Filion et al., 2010; Kubben et al., 2012; Shah et al.,
2013; Zullo et al., 2012). These LAD maps have consistently demonstrated that about
40% of the genome is found within 1500 lamina-bound domains of an average size of
about 250 kilobases. This suggests that a number of genes are contained and silenced
within these regions, however an even larger proportion of the genome is not actively
bound to the nuclear lamina. Closer analysis of the makeup of these LADs finds that
they tend to be gene-poor regions with little detectable transcriptional activity. While this
is consistent with the model that lamina-bound, heterochromatic regions tend to be
silenced, there are large portions of the genome that are not found in these domains but
are still repressed. It is very unlikely that LADs and changes in nuclear architecture are
the exclusive mechanisms for transcriptional regulation in progenitor cells. It is also
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unlikely that the entirety of the phenotypes observed in Hdac3-deficient mice or in
models lacking other lamina-related proteins is due to altered nuclear architecture.

Is neural crest regulation dependent on LADs?

To date, no study has linked nuclear architecture with regulation of the neural
crest. The most closely related work has been by our lab and the Olson group, targeting
epigenetic modifiers required for lamina-mediated silencing. Deletion of Hdac3 in neural
crest (see Chapter 2) results in cleft palate, microcephaly, tooth hypoplasia and outflow
tract defects (Singh et al., 2011b, 2013). While these defects have not been directly
attributed to altered chromatin organization, Hdac3 serves as a tether between the
nuclear lamina and repressed loci. A straightforward first experiment is to map LADs in
wild-type versus Hdac3-deficient neural crest derivatives. Loss of Lamin B1 occupancy
at Bmp, Msx or Notch loci would be intriguing preliminary evidence of altered nuclear
architecture affecting expression of gene regulatory networks.
Deletion of Hdac1 in neural crest has been previously described (Haberland et
al., 2009a). Unlike Hdac3, loss of Hdac1 does not result in an overt phenotype or
embryonic lethality. Given that Hdac1 functions as a mediator of deacetylation and
repression of genes tethered at the nuclear lamina (Milon et al., 2012), I hypothesize that
maintaining a locus at the nuclear periphery is more critical to gene function than
deacetylation or other mechanisms of repression once the locus is at the lamina. The
Olson group also described severe craniofacial defects with loss of Hdac8, another class
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I Hdac (Haberland et al., 2009a). While no role for Hdac8 at the nuclear periphery has
been described, it is possible that this enzyme functions in lamina-mediated silencing.

What comes first, tethering or repression?

The most convincing evidence that relocating chromatin to the nuclear lamina is
sufficient for repression stems from artificial tethering experiments performed by Singh
and Reddy (Reddy and Singh, 2008; Reddy et al., 2008). Through creative repurposing
of the lac operon, the authors were able to inducibly tether a gene of interest to the
nuclear lamina. First, the lac repressor (LacI) is fused to a structural element of the
nuclear lamina (e.g. Emerin or Lamin B1). Then, the lac operator (LacO) sequence is
cloned downstream of a reporter transgene and introduced into a cell stably expressing
the LacI fusion protein. Upon removal of isopropyl-β-D-thio-galactoside (IPTG), the
repressor fusion protein reversibly binds to the lac operator sequence, retaining the
reporter gene at the nuclear periphery. LacI-LacO mediated tethering of a reporter gene
significantly decreased its expression, providing direct evidence that the nuclear
periphery is a “silenced environment” capable of repressing genomic loci brought in
close proximity.

While these experiments elegantly demonstrate the capacity of the perinuclear
region to repress transcriptional activity, they do not preclude the model that under
native conditions a locus is first epigenetically silenced before being retained at the
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nuclear periphery. To test this alternative hypothesis, a transgene could be artificially
decorated with histone modifications and tracked to determine whether it migrates to the
nuclear periphery. One potential system for modifying histone proteins at a specific gene
is to generate a version of Cas9 fused to various epigenetic modifiers (e.g. Hdacs,
histone methyltransferase, etc.) and target the gene of interest by transfecting small
guide RNAs complementary to the transgene sequence. The epigenetic modifying
enzymes would be directed to the transgene, presumably marking the chromatin for
repression. This approach would determine whether epigenetic silencing of a gene is
sufficient to induce translocation to the nuclear periphery.

Are there epigenetic factories at the lamina?

The subnuclear region near the lamina and inner nuclear membrane is often
described as a “silenced environment.” Active tethering of transgenes to the nuclear
periphery reduces expression at the RNA level (Reddy et al., 2008). Mapping studies in
vivo and in vitro indicate that genomic regions bound at the nuclear lamina are typically
silent, with relatively low transcriptional activity (Guelen et al., 2008; Kohwi et al., 2013;
Peric-Hupkes et al., 2010; Zullo et al., 2012). Despite these correlative studies in several
systems, the precise mechanism by which tethered genes are repressed remains
unknown.
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Circumstantial evidence from a several studies suggests that a host of epigenetic
regulator enzymes and complexes reside at the nuclear periphery (Demmerle et al.,
2012; Guarda et al., 2009; Hurd et al., 2010; Milon et al., 2012; Pegoraro et al., 2009;
Shevelyov and Nurminsky, 2012). These proteins include epigenetic “writers” like HATs,
“erasers” like Hdacs and “readers” like CHD7/8. These enzymes are also found within
larger complexes at the nuclear membrane including NuRD and NCoR-SMRT. These
data are partly accumulated from immunoprecipitation studies identifying interacting
partners of structural proteins within the nuclear lamina and membrane. Much work
needs to be done to determine whether these epigenetic complexes are enriched at the
nuclear periphery or simply appear in immunoprecipitation studies based on stochastic
abundance. Given our findings of Hdac3 residing at the nuclear periphery and acting as
a LAD tether, there is reason to suspect that these epigenetic regulators may have
unexpected repressive functions to maintain the “silenced environment” of the nuclear
periphery.

LADs vs nuclear pore complex vs nuclear matrix

While gene positioning at the nuclear periphery typically results in binding to the
nuclear lamina and transcriptional repression, this is not always the case. The nuclear
membrane is also decorated with thousands of nuclear pore complexes (NPC). These
large protein complexes of at least 30 different nucleoporin proteins are typically thought
of as regulators of selective transport in and out of the nucleus. Nuclear pore proteins
also interact with chromatin and several studies have linked chromatin-nuclear pore
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complex interactions with gene activation (Arib and Akhtar, 2011; Van Bortle and
Corces, 2013; Brown et al., 2008; Chambeyron and Bickmore, 2004; Meister et al.,
2011). In cardiomyocytes, class IIa Hdac4 can physically interact with Nup155 to
mediate chromatin-nucleoporin association and repress Hdac4 target genes (Kehat et
al., 2011). Work in differentiating ESCs has demonstrated that as lineage-specific genes
are expressed, some of the corresponding genomic loci move towards the nuclear
membrane and interact with the nuclear pore complex (Chambeyron and Bickmore,
2004). One intriguing model for this phenomenon is that genes bound at the nuclear
pore are optimally positioned for sensing and reacting to incoming signals from the
cytoplasm. Tethering a gene to the nuclear pore complex may poise the locus for
activation by cytoplasmic or extracellular signals. In support of this hypothesis, our lab
has preliminary data that addition of retinoic acid, a potent activator of Hox genes, draws
the HoxA locus to the nuclear periphery. While additional work must be done to
distinguish interactions with the pore versus interactions with the nuclear lamina, the
notion that gene repositioning serves as a mechanism for potentiating signaling
cascades is very enticing.

As a counterpart to gene repression at the nuclear lamina, recent studies
suggest that the nuclear matrix may play a role in gene activation (Li and Reinberg,
2011; Skowronska-Krawczyk et al., 2014). The nuclear matrix is a network of filaments
within the nucleus without a well-established function. The matrix is thought to aid in
cargo transport within the nucleus and positioning of the chromosomes during mitosis,
however a novel function as a transcriptional co-activator has emerged. Work by
Rosenfeld and colleagues demonstrated that Pit1, a homeodomain transcription factor,
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requires interaction with both β-catenin and the nuclear matrix protein matrin-3 to
activate downstream target genes. Through elegant loss-of-function and artificial
tethering experiments, the authors establish that matrin-3 is required for recruitment of
co-activators including p300 and ultimately gene transcription. As additional reports of
lamina, nuclear pore complex and matrix-mediated transcriptional regulation emerge, the
relevance of these mechanisms in a developmental context will have to be established.

How to visualize and manipulate nuclear architecture?

As our understanding of the relevance of nuclear architecture on development
and progenitor cell biology deepens, the dynamics of chromatin organization remain
undetermined. The current approaches for visualizing specific genomic loci rely primarily
upon in situ hybridization of locus-specific probes in fixed, permeabilized cells. While this
technique enables clear visualization of a genomic locus of interest, it limits analysis to a
single timepoint, preventing studies of chromatin movement over time. It is possible to fix
samples at several timepoints to track changes over the duration of the experiment,
however without live imaging it is not possible to determine what changes have taken
place in the same cell over time. Two novel approaches to live chromosome tracking
have recently been described. The van Steensel group has published a method for live
imaging based upon a modification of DamID. DNA adenine methyltransferase (Dam) is
fused to the nuclear lamina and stably expressed in a cell, adding methyl-adenine bases
to genomic loci that have come in contact with the nuclear lamina. By simultaneously
expressing a fluorescently-tagged DpnI restriction enzyme, the methylated loci are
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bound by DpnI-GFP and visualized (Kind et al., 2013). In parallel, the Huang group
modified the CRISPR-Cas9 genome editing system to visualize specific genes by
fluorescently-tagging the Cas9 enzyme (Chen et al., 2013). By introducing at least 30
guide RNAs to a gene of interest, the authors were able to tile Cas9-GFP molecules
along the genomic locus and visualize it in real time. The advantage of the CRISPRbased approach to the Dpn-based approach is that addition of sequence-specific guide
RNAs allows tracking of a specific gene. These methods may prove useful to
determining the dynamics and timeframe of nuclear architecture changes in real time in
differentiating cells or even in vivo in C. elegans or zebrafish.

To directly examine the significance of nuclear architecture changes on cell
function or progenitor cell behavior, the field needs a system for manipulating gene
position and analyzing the downstream effects. Much like the artificial tethering
experiments using LacO-LacI, I have bound Hdac3 and any Hdac3-occupied genes to
the nuclear periphery by fusing the protein to Lap2β, a factor embedded within the inner
nuclear membrane (see Chapter 3). I was able to show that this lamina-bound form of
Hdac3 is sufficient to repress cardiac progenitor differentiation into myocytes, similar to
wild-type, unbound Hdac3. To extend these experiments further, it is essential to be able
to directly affect positioning of an endogenous gene. One potential method is to modify
the CRISPR-Cas9 system by fusing Cas9 to Lap2β, sequestering it at the nuclear
periphery. Upon introduction of guide RNAs specific to a gene of interest, Cas9 will bind
to the sequence complementary to the guide RNA and retain the gene at the nuclear
membrane. This system could be leveraged to investigate the effect of repositioning any
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gene to the nuclear periphery in any cell type, finally addressing the question of what
effect gene location has on cell function and development.

Concluding Remarks

In this dissertation I have studied the role of Hdac3 in neural crest and cardiac progenitor
cell commitment. This work describes the capacity of an epigenetic modifier to
coordinate expression of broad gene programs controlling cell behaviors including
proliferation, survival and differentiation. One of the most exciting findings is that Hdac3
functions in a deacetylase-independent manner to repress lineage-specific genes by
tethering the relevant genomic loci at the nuclear lamina. This novel mechanism of
regulation introduces chromatin dynamics within the nucleus as a system by which
progenitor cells promote differentiation into a specific cell type. This work raises the
possibility of tailor-made Hdac inhibitors used to regulate cell fate without affecting
deacetylase activity or other enzymatic function. Potential clinical applications include
expansion and differentiation of cardiac progenitor cells ex vivo or influence of progenitor
cell commitment in vivo. It will be interesting to see the effect this work has on bridging
the fields of developmental biology and nuclear architecture to influence future studies.
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